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  VIICHAPTER 1 
 
LITERATURE REVIEW 
 
1.1 Introduction 
 
The genus Mycoplasma has more than a hundred species, with a G+C (Guanine 
Cytosine) content of 23-40 % (Kleven, 2003). The most important characteristics 
of the members belonging to this genus is their lack of cell wall, utilization of 
UGA, a universal bacterial stop codon, to code for tryptophan; as well as the 
utilization of sterols to strengthen the outermost trilaminar membranes (Hnatow 
et al., 1998). These membranes act as barriers that protect the contents of the 
Mycoplasma cell. Both pathogenic and non-pathogenic species are found in the 
genus and most species are host-dependent and survive for a limited period 
outside the host. Boguslavsky et  al.  (2000) reported that a bleb at the tip 
organelle initiates cytadhesion to host cell membranes in pathogenic species 
during pathogenesis. 
 
Mycoplasma  gallisepticum, an avian pathogen, belongs to this group and is 
considered to be the most pathogenic of all avian Mycoplasma pathogens 
(Kleven, 2003). Infection with M. gallisepticum leads to reduced egg production, 
growth and hatchability rates thus causing great economic losses (Ferguson et 
al., 2004; Liu et al., 2001; Marois et al., 2001). Similar clinical signs have been 
reported in other avian Mycoplasma infections such as those of M. synoviae and 
M. meleagridis in less severity, though M. gallisepticum has a smaller genome 
size (Levisohn & Kleven, 2000). The size of the genome is 996 422 base pairs 
(bp)-long with 742 genes as concluded in the R-strain by Papazisi et al. (2003). 
Non-pathogenic species include M. gallinarum and M. gallinaceum, and should 
be differentiated from pathogenic species as both are usually isolated together 
(Hong  et al., 2005a). This is probably due to similar growth conditions and 
nutritional requirements.  
  1Differentiation of Mycoplasma species based on morphological characteristics is 
non-effective due to pleomorphic conformation by these species, as well as the 
lack of ability for Gram staining characterization. Boguslavsky et al. (2000) have, 
however reported the conformation of M. gallisepticum and human Mycoplasma 
species to a flask-like shape with attachments at the tip. Serological methods on 
the other hand, have been shown to be more effective, though with certain 
limitations. The most effectiveness was achieved with utilization of molecular 
methods in both the identification and differentiation of M. gallisepticum strains. 
 
Besides playing a role as pathogens, Mycoplasma species have been nicknamed 
the “crabgrass” of tissue cultures. This is due to the very high levels of 
contamination in tissue cultures. In a review by Razin (1996), the infection is said 
to be persistent, frequently difficult to detect and diagnose, and difficult to cure. 
The origin of contaminating Mycoplasma is in components of the culture medium, 
particularly serum, or in the microbiota of the technician’s mouth, spread by 
droplet infection. 
     
1.2 Classification of M. gallisepticum   
 
M. gallisepticum belongs to the division Firmicutes, class Mollicutes, order 
Mycoplasmatales and the family Mycoplasmataceae (Ley, 2003). Despite their 
lack of cell wall, Mycoplasma are classified into the phylum Firmicutes which 
consists of low G+C Gram-positive bacteria such as Clostridium, Lactobacillus 
and Streptococcus based on the 16S rRNA gene analysis. This is the reason 
some literature refers to Mycoplasma as Gram-positive bacteria.   
Mycoplasmatales is one of the four cultured orders of the class Mollicutes and 
contains a single family Mycoplasmataceae with two genera: Mycoplasma and 
Ureaplasma.  
 
The first classification and differentiation of M. gallisepticum from other avian 
Mycoplasma species was done by serotyping and designated serotype A. The 
  2species designation, M. gallisepticum, was made in 1960 by Edward and 
Kanarek (1960). Bradbury et al. (1993) worked with Mycoplasma species that 
had phenotypic and antigenic similarities to M. gallisepticum, differentiated them 
by molecular techniques and designated them M. imitans. 
 
1.3 Avian mycoplasmosis  
 
1.3.1 Diagnosis 
     
  M. gallisepticum is the primary causative agent of Chronic Respiratory Disease 
(CRD) (Papazisi et al., 2002), and can induce avian mycoplasmosis especially 
under conditions of management stresses and/or other respiratory pathogens. 
Ley  et al. (2003) and Hong et al. (2005b) reported that infection with M. 
gallisepticum induces further opportunistic infections by Escherichia coli and/or 
viruses but most notably, M. synoviae can also cause infections when M. 
gallisepticum infection becomes systemic. Flocks may have serological evidence 
of the infection with no obvious clinical signs, especially if they encountered the 
infection at a younger age and have partially recovered. Male birds are said to 
have more pronounced signs, and the disease is more severe during winter (Ley, 
2003). 
 
Because of the expansion of poultry production and construction of large 
multiage production complexes in a restricted geographic area, it is becoming 
more and more difficult to maintain M. gallisepticum- and M. synoviae-negative 
flocks and therefore the application of vaccination and medication is needed to 
reduce the production losses and to prevent the transmission of the infection 
(Hong et al., 2005b). In recent years, a reemergence of Mycoplasma infection 
has been observed in poultry, possibly due to these practices of placing large 
poultry populations in small geographic areas under poor biosecurity (Liu et al., 
2001).  
 
  31.3.2 Transmission and Infection 
 
M. gallisepticum-CRD is transmitted vertically through infected eggs and 
horizontally by inhalation of contaminated dust, airborne droplets and feathers 
resulting in rapid disease transmission throughout the flock by subsequent close 
contact (Papazisi et al. 2002; Talha et al., 2003). Vertical transmission has been 
successfully induced following experimental infection of susceptible chickens 
(Talha et al., 2003). Due to the inability of M. gallisepticum to survive long periods 
outside the host, carrier birds are very essential to its epidemiology. The 
organism has been reported to have survived in the human nasal passage for 24 
hours; on straw, cotton and rubber for 2 days, on human hair for 3 days and on 
feathers for 2-4 days as cited by Ley (2003). 
 
In a study by McMartin and co-workers (1987), the horizontal transmission of M. 
gallisepticum was described in four phases: phase 1, a latent phase (12-21 days) 
before antibodies were detected in inoculated birds; phase 2, a period (1-21 
days) in which infection gradually appeared in 5-10 % of the population; phase 3 
a period (7-32 days) in which 90-95 % of the remaining population developed 
antibodies; and the fourth phase, a terminal phase (3-19 days) in which the 
remainder of the population became positive. Increasing the population density 
increased the rate at which horizontal spread occurred. Horizontal spread has 
also been found to be much more effective than vertical transmission. When the 
organism has been successfully transmitted, infection can then proceed.   
 
Before infection can occur, the Mycoplasma cell should bind to the host cell 
membranes. This attachment is mediated by specific interactions between 
Mycoplasma cytadhesins and their corresponding host-cell receptors. The ability 
of Mycoplasma to firmly adhere to cells initiates the process that results in host 
cell alterations and pathogenesis. Though pathogenic Mycoplasma are said to be 
typically non-invasive organisms that merely colonize epithelial surfaces of the 
  4host tissues, pathogenic human Mycoplasma: M. penetrans, M. pneumoniae, M. 
genitalium and M. fermentas are known to be invasive.  
 
More recently, Winner and co-workers (2000) reported that M. gallisepticum is 
the only avian Mycoplasma species that is invasive. Using chick embryo 
fibroblast (CEF) cells, Boettger and Dohms (2006) observed the same tendency, 
while  M. synoviae and non-pathogenic Mycoplasma were reportedly non-
invasive. Due to the invasiveness of M. gallisepticum, the mechanism of host-cell 
oxidative damage might be similar to that proposed for M. pnemoniae, as shown 
in Figure 1.1 below: 
 
 
Figure 1.1: Proposed mechanism of oxidative damage to host cells by adhering M. 
pneumoniae (Razin, 1996)      
 
 
  5Infection in chickens may superficially resemble respiratory disease caused by 
other pathogens such as mild strains of Newcastle disease and Avian Infectious 
Bronchitis, and these diseases may also be present in combination with M. 
gallisepticum. The World Organization for Animal Health (OIE) reported that M. 
gallisepticum in turkeys may be confused with Avian pneumovirus infections and 
the presence of sinusitis may also suggest infection with Pasteurella multocida, 
Chlamydia spp. or M. synoviae.  
    
1.3.3 Clinical signs and Isolation
 
M. gallisepticum infection has a wide variety of clinical manifestations, of which 
CRD is the most significant in chickens and turkeys. The pathology associated 
with this disease is characterized by severe air sac infection where M. 
gallisepticum is the primary pathogen (Hong et al., 2005b; Liu et al.,2001). Marois 
et al., (2001) reported M. gallisepticum causing upper respiratory tract infections 
in patridges and pheasants.  
 
M. synoviae on the other hand, following M. gallisepticum infection, can result in 
respiratory disease in chickens and turkeys, while M. iowae infection leads to 
reduced hatchability and embryo mortality in turkeys (Hong et al., 2005b). The 
infections can be asymptomatic but are mostly associated with coryza, 
conjunctivitis, coughing and sneezing.  
 
Other symptoms reported are nasal exudates, tracheal rales and breathing 
through a partially open beak with unilateral and bilateral sinusitis occurring 
particularly in turkeys and game birds. In these poults, infraorbital sinuses can 
become so swollen that the eyelids are closed as illustrated in Figure 1.2.  
 
Two cases of M. gallisepticum infection in different avian species in backyard 
gamebird operations investigated by Bencina et al. (2003) in Slovenia resulted in 
20% mortality in pheasants due to severe respiratory disease but very low 
  6pathogenesis of the organism was reported for chickens and turkeys reared at 
the same site. Infected finches may reveal ocular and nasal discharge and 
swollen eyelids in addition to conjunctivitis, while in chickens and turkeys M. 
gallisepticum can cause acute respiratory disease especially in young birds, with 
the turkeys showing more susceptibility. A more chronic form of the disease may 
occur and cause reduced egg production in breeders and layers. Kleven et al. 
(2004) also reported fowl cholera in Nebraskian turkey flocks from which M. 
gallisepticum strains K4029 and K4043 were first isolated in 1995. 
 
 
A B
Figure 1.2: A, Healthy turkey before infection; B, Clinical signs of Mycoplasma 
gallisepticum. The arrow shows the swollen sinuses that led to closure of the 
eye.(www.poultrymed.com) 
 
Samples are taken from live birds, fresh carcasses or carcasses of birds that 
have been frozen when fresh and should be maintained under conditions that will 
preserve them. Samples like tracheal and lung washes are usually maintained on 
ice for about 3-4 hours then stored at -20
0C for subsequent analysis (Papazisi et 
al., 2002).  
 
Small pieces of tissue should be placed in Mycoplasma broth and swabs should 
be vigorously agitated in 1-2 ml of Mycoplasma broth and then discarded if 
transportation is needed. In such cases, a means of chilling should be included 
and dilution done because the presence of specific antibodies or antibiotics or 
other inhibitory substances in tissues may inhibit Mycoplasma growth unless they 
are diluted out.   
  71.3.3.1 Isolation from live birds 
 
From live birds, isolates may be obtained from the sinus exudates (Ferguson et 
al., 2005) as well as conjuctival sinuses from clinically ill birds (Ley et al., 1997a). 
Sera and nasal washes are also performed prior to procedures such as 
vaccination (Papazisi et al., 2002). Bencina et al. (2003) reported on an M. 
gallisepticum strain that was highly pathogenic for chicken embryos isolated from 
the sinus of a pheasant.  
 
When taking swab samples, isolation can be done from the choanal cleft, 
oropharynx, oesophagus, trachea, cloaca and phallus. Blood collection is another 
option for M. gallisepticum isolation and has been previously collected from the 
wing vein of chickens. Nasal washes are performed with the head of the bird held 
at a slightly downward angle and wash samples are collected by gravity into 
sterile plastic beakers (Papazisi et al., 2002). M. gallisepticum may also be 
present from oviducts and semen of a rooster (Ley, 2003). 
 
1.3.3.2 Isolation from dead birds 
 
In the case of dead birds, samples may be taken from the nasal cavity, 
infraorbital sinus, trachea or air sacs while exudates can be aspirated from the 
infraorbital sinuses and joint cavities (OIE). In a study conducted by Bencina et 
al. (2003) M. gallisepticum  strain ULB 992 that synthesizes a small amount of M. 
gallisepticum C3, a truncated form of M. gallisepticum C1 also lacking PvpA, was 
isolated from the infraorbital sinus of a dead peafowl. 
 
1.3.3.3 Isolation from eggs 
 
Samples are also taken from embryonated eggs, dead-in-shell embryos, 
chickens or poults that have broken the shell but failed to hatch. When using 
  8embryonated eggs, samples may be taken from the inner surface of the vitelline 
membrane and from the oropharynx and airsacs (OIE). 
 
1.3.4 Growth of M. gallisepticum 
 
The members of the genus Mycoplasma are known to require very complex 
media for adequate growth. This is attributed to their replication, the high 
interdependence between the organisms and their hosts as well as the sterol 
requirement for the trilaminar membranes. In addition to these properties, M. 
gallisepticum  is fastidious in vitro (Levisohn & Kleven, 2000) and tends to grow 
very slowly on a protein-rich medium containing 10 to 15% added animal serum 
and is rather resistant to certain antimicrobial agents which are frequently added 
in the medium to retard growth of contaminant bacteria and fungi (Hong et al., 
2005a). Several suitable culture media have been formulated such as 
Mycoplasma agar (Avian Mycoplasma solid medium from Mycoplasma 
experience, Reigate, U.K.) or Mycoplasma broth (Avian Mycoplasma liquid 
medium from Mycoplasma experience) (Mekkes & Feberwee, 2005).  
 
The medium developed by Fey et al. (as cited by Ley, 2003) is widely used for 
isolation of M. gallisepticum and  M. synoviae.  Mycoplasma medium generally 
contains a protein digest and a meat-infusion base supplemented with serum or a 
serum fraction, yeast fraction, glucose and bacterial inhibitors. M. gallisepticum is 
cultured in Mycoplasma broth or on agar at 37
0C in a CO2 –rich atmosphere until 
the broth shows colour change or colonies appear on plates (Harasawa et al., 
2004).  
 
Increased humidity and tension in the atmosphere have been reported to 
enhance growth. Such conditions can be achieved by the inclusion of damp 
paper or cotton wool, and by flushing the container with 5-10% CO2 in nitrogen, 
by placing a lighted candle in the container or by using a CO2 incubator or 
suitable gas-generating system. The glucose in the medium is fermented and this 
  9allows for the pH to be lowered, causing the phenol red indicator to change from 
red to orange/yellow thus making it possible to visually detect growth in broth 
tubes (Ley, 2003). 
 
1.3.5 Serology 
 
Serological procedures are useful for flock monitoring in M. gallisepticum control 
programs and to aid in diagnosis when infection is suspected. A positive 
serological test, together with history and signs typical of the M. gallisepticum 
disease, allows a presumptive diagnosis pending isolation and/or identification of 
the organisms (Ley, 2003). Immunological and DNA detection methods can be 
used to identify mycoplasmal isolates. These include the Indirect Fluorescent 
Antibody (IFA) and Immunoperoxidase (IP) tests, both of which are simple, 
sensitive, specific and rapid to perform. Growth inhibition (GI) and metabolism 
inhibition (MI) tests can also be done in addition to IFA and IP (OIE). 
 
  Ferraz and Danelli (2003) studied hemagglutination inhibition (HI) tests and 
immunoblot assays to detect antigenic differences among vaccine and wild M. 
gallisepticum strains. Immunoblot assay resulted in a Polyclonal antibody (PCA) 
reactivity pattern that did not vary much from that of HI. For their preparation of 
cellular antigen, an M. gallisepticum strain was firstly stored in glycerol, with 
lyophilized vaccine strain being maintained at 4
0C, while the other vaccine was 
maintained at -20
0C. All strains are then cultivated in Hayflick modified medium 
with 10% equine serum (Ferraz & Danelli, 2003). Western blot followed these 
preparations and the nitrocellulose sheet that had been used to observe the 
peptide bands was incubated with PCA. 
 
  Direct immunofluorescence can also be used to identify M. gallisepticum 
(Ferguson et al., 2004). For GI and MI tests, the OIE states that purified (cloned) 
cultures are required but not for the IFA and IP tests. IFA and IP are very good 
tools as they can detect the presence of more than one species of Mycoplasma, 
  10as the colonies specific for the antiserum will react while others will not. Kleven 
and co-workers (2004) tested sera for antibody against M. gallisepticum using 
serum plate agglutination (SPA) and HI. Agglutination reactions were graded 
from 0 (negative) to 4 (strong, rapid reaction) and agglutination scores ≥1 and HI 
titers of ≥1:40 were considered positive. 
 
Immunofluorescence and IP procedures for diagnosis are generally applied to 
suspected laboratory isolates rather than directly to infected exudates. This is 
because the organisms are too small to be recognized conclusively under the 
light microscope and because the corresponding negative and positive control 
exudates/tissue is unlikely to be readily available.  
 
In the GI test, the growth of Mycoplasma is inhibited by specific antiserum, 
enabling species to be identified. It is relatively insensitive and sera must be at a 
high titer, monospecific and prepared in mammalian hosts as poultry sera do not 
inhibit Mycoplasma growth efficiently (OIE). Ferraz and Danelli (2003) made use 
of HI tests because M. gallisepticum is capable of haemagglutinating avian red 
blood cells (RBCs) and specific antibodies in sera cause inhibition.  
 
Furthermore, a strain that grows well and haemagglutinates reliably should be 
selected. The HI test requires a satisfactory haemagglutinating M. gallisepticum 
antigen, washed chicken or turkey RBCs and the test sera. The antigen can be 
either a fresh broth culture or a concentrated washed suspension of M. 
gallisepticum in phosphate buffered saline.  
 
In addition to the haemagglutinating antigens, other antigens of great interest are 
the cytadhesins. Some of these cytadhesins and heamagglutinins have been 
described as immunodominant and these are proteins or lipoproteins with 
molecular weights of 60-75 kDa (Ley, 2003).  
 
 
  111.4 The complete genome of M. gallisepticum 
 
Due to their degenerative evolution, it is not surprising that all Mycoplasma 
species have minimal genetic information. One of the first species whose 
genome was completely sequenced is M. genitalium that is 580 kb long. More 
species have been sequenced since then, including M. gallisepticum.  
 
Papazisi et al. (2003) completed the genome of M. gallisepticum using the R-
strain. The authors were able to assign function to 469 of the 742 genes in the 
genome. A total of 150 genes were found to encode for conserved hypothetical 
proteins while 123 remain as hypothetical proteins. Due to this large number of 
putative proteins to which function has not been assigned, the inner functioning 
of this pathogen is relatively unknown.  
 
Important proteins, the cytadhesins, are also encoded for in the genome and are 
known to play a fundamental role in M. gallisepticum adhering to the host cells as 
pathogenesis is initiated. There are about five or more identified cytadhesins but 
only three will be concentrated upon in this review. These cytadhesins show 
homology in all M. gallisepticum strains and homology to the human Mycoplasma 
pathogens has also been reported Hnatow et al. (1998). 
 
 Furthermore, the genome contains two copies of the rRNA genes and 33 tRNA 
genes that correspond to all amino acids. One set of the rRNA genes is 
organized as an operon, with adjacent 16S, 23S and 5S genes; and a second 
copy of the 16S rRNA gene lies 221 kb upstream of the 23S and 5S rRNA genes.  
 
A single polypeptide release factor (prfA) was identified, consistent with the use 
of only UAA and UGA as stop codons. Similar to most bacteria, the origin of 
replication (oriC) is located in the region of the dnaA gene. Comparative analysis 
of the oriC regions of sequenced Mycoplasma genomes predicts putative DnaA 
boxes in the area surrounding the dnaA gene Papazisi et al. (2003).  
  121.4.1 Cytadhesion genes
 
1.4.1.1 Cytadhesion gene Mgc2 
 
The Mgc2 gene is 912 bp-long and encodes the 32.6 kDa cytadhesion protein 
Mgc2 that is clustered at the tip organelle and was as such functionally implicated 
in cytadhesion (Boguslavsky et al., 2000). Comparison of Mgc2 to the M. 
pneumoniae protein P30 and the P32 sequences of M. genitalium showed 40.9% 
and 31.4% homology, respectively, as determined by Hnatow et al. (1998). This 
is of notable importance as P30 and P32 also function as cytadhesins that aid 
their respective Mycoplasma  in adhering to mucosal membranes and hence 
initiate infection in humans. Mgc2 has the same function in avian Mycoplasma 
species.  
 
Hnatow et al. (1998) further reported that there are 30 shared proline residues at 
amino acid positions 73 in P30, 68 in P32 and 62 in Mgc2. In addition to this, the 
carboxy end of Mgc2 (aa. 185 to 304), like that of P30 and P32, has the 
characteristics of cytoskeletal matrix proteins and the carboxy end of the 
molecule is distinguished by two identical overlapping 24 amino acid sequences. 
The Mgc2 gene is fairly well conserved in M. gallisepticum and can be used as a 
basic reference in molecular identification of isolates. Using suitable restriction 
enzymes on Mgc2, M. gallisepticum isolates can be differentiated to strain level.         
 
1.4.1.2 Cytadhesion gene PvpA 
 
The PvpA gene is the most recently identified cytadhesion gene to Mgc2 and 
GapA and is similar in function to both. The cytadhesion protein encoded for by 
PvpA is designated PvpA and exhibits higher homology to the P30 and P32 
proteins than Mgc2, with 54 and 52% homology, respectively (Boguslavsky et al., 
2000). PvpA has several important features: (i) it is an integral membrane surface 
protein with free C-terminus, (ii) it  possesses an epitope shared by three distinct 
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spontaneous high-frequency variation in expression, (iv) exhibits size variation 
among strains and (v) is not a lipoprotein. Liu et al. (2001) reported that 
structurally, PvpA is a non-lipid integral membrane protein with a surface-
exposed C-terminal portion.  
 
The surface-exposed C-terminus of PvpA has high proline content (28%) and 
contains identical direct repeat sequences of 52 amino acids each designated 
DR-1 and DR-2. The presence of proline-rich regions in the surface-exposed C-
terminus domains of other pathogenic Mycoplasma adhesins suggests an 
important role of these domains in the function of PvpA as an adhesin. 
 
1.4.1.3 Cytadhesion gene GapA 
 
The GapA gene is 2 895 bp-long and encodes a 105 kDa protein, GapA (Goh et 
al., 1998). The GapA nucleotide sequence analysis by the same authors 
revealed that there is 45% homology to the M. pneumoniae P1 gene, 46% 
homology to the M. genitalium MgPa gene and 47% homology to the M. pirum 
P1-like protein gene. GapA has an A-T content compared to 64, 46.6 and 72 
mol%, for the P1, MgPa and the P1-like protein genes, respectively.  
 
Similar to P1 and MgPa genes, GapA is a central gene in a multi-gene operon, 
but unlike the P1 and MgPa genes, there is only a single copy of gapA in the 
genome. GapA is a trypsin-sensitive surface-exposed protein and results in about 
64% inhibition of attachment assays using the anti-GapA Fab fragments. 
Intraspecies strain variation in the size of GapA has been observed and has 
molecular weights of approximately 98.1 kDa and 110 kDa in different strains.   
 
 
 
 
  141.5 Molecular differentiation techniques 
 
1.5.1 Polymerase Chain Reaction (PCR) 
 
PCR has been widely used in many differentiation studies as it gives the desired 
amount of DNA that is appropriate for evaluation as well as indicating 
complementarity of primers to template sequences. Kiss et al. (1997) used PCR 
in differentiation of avian Mycoplasma. In the study, primers complementary to 
the 16S rRNA genes were used in detection of the organisms. The general 
primer pair used was GPO-3: 5’-GGG AGC AAA CAG GAT TAG AAT ACC T-3’ 
and MGSO: 5’-TGC ACC ATC TGT CAC TCT GTT AAC CTC-3’ and for the 
detection/exclusion of M. gallisepticum a different primer pair with sequences: 5’-
AAC ACC AGA GGC GAA GGC GAG G-3’ and 5’-ACG GAT TTG CAA CTG TTT 
GTA TTG G-3’ was used.  
 
Garcia  et al. (2005) modified the standard PCR, where four generic M. 
gallisepticum PCRs were compared for analytical specificity and sensitivity using 
tracheal swabs. The four PCRs used are the 16S rRNA PCR, three newly 
developed PCRs that target surface protein genes (Mgc2, LP and gapA, the latter 
two being nested). Nested PCR requires two sets of primers used in two 
successive PCR runs, the second set intended to amplify a secondary target 
within the first run product. Another modification is the RT-PCR where a known 
sequence from a cell or tissues’ RNA is amplified, isolated or identified. It is 
essentially a normal PCR preceded by reverse transcription of RNA to cDNA. 
 
For further evaluation of diagnostic specificity, Garcia et al. (2005) used a 
licensed M. gallisepticum DNA Test kit (IDEXX laboratories, Inc). The kit is a 
nonradioactive probe-based test utilizing PCR amplification for the specific 
detection of M. gallisepticum from chicken and turkey tracheal swab samples. 
PCR amplification procedure utilizes two primers complementary to the M. 
gallisepticum sequence. The primers are used in conjunction with AmpliTaq® 
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enhancement of sensitivity. The third primer, labeled with an enzyme, is used as 
a sequence-specific hybridization probe to provide colorimetric detection of the 
amplified target DNA.   
 
1.5.2 Restriction Fragment Length Polymorphism (RFLP) 
 
RFLP is conducted by PCR-amplified DNA that is then cut into restriction 
fragments using suitable endonucleases which only cut the DNA molecule where 
there are recognition sequences. Restriction fragments are then separated 
according to length by agarose gel electrophoresis. In a study by Kiss et al. 
(1997), two restriction enzymes BamHI and RsaI were used for the distinction of 
the amplified fragments of approximately 270 bp from Mycoplasma isolates. The 
enzymes were able to differentiate between three Mycoplasma species: M. 
synoviae, M. iowae and M. meleagridis.  
 
In a similar study by Garcia et al. (1995), a region in the 16S rRNA sequence was 
amplified using a single set of primers in M. gallisepticum, Mycoplasma synoviae 
and M. iowae DNA. The primers selectively amplified a 780 bp DNA fragment in 
the three organisms but did not amplify other avian Mycoplasma  or other 
bacteria. The PCR product was differentiated by RFLP with the restriction 
enzymes  HpaI,  HpaII and MboI. The authors also concluded that preliminary 
results from field samples suggest that this technique could be a useful and rapid 
diagnostic test for the detection of these three pathogenic poultry Mycoplasma.  
 
Lauerman  et al. (1995) used RFLP in differentiation of nine species of 
Mycoplasma by cleaving them with 24 restriction enzymes. Four (DraI,  MseI, 
RsaI, Tsp509I) of the 24 enzymes cut the PCR amplicon of all nine Mycoplasma 
species and thus total differentiation of the strains was achieved.  
 
 
  161.5.3 Randomly Amplified Polymorphic DNA (RAPD) 
 
RAPD is a PCR assay where segments of unknown DNA are amplified. Primers 
with an arbitrary sequence are designed and a PCR reaction is run followed by 
agarose gel analysis to observe if any DNA segments were amplified in the 
presence of the arbitrary primers.  
 
Ferguson et al. (2005) conducted a study where a total of 77 M. gallisepticum 
field isolates from the USA, Israel and Australia, as well as ten reference strains 
were characterized by RAPD analysis in concert with gene-targeted sequencing. 
Characterization was documented by constructing RAPD groups according to the 
relatedness of the isolates to the reference strains. Charlton et al. (1999) used 
this technique for differentiation between 7 strains of M. gallisepticum by 
screening six commercially available primers or primer combinations for their 
ability to differentiate vaccine and type strains, however the primers were 
unsuitable for strain differentiation, a drawback that is associated with this 
technique. To solve this, certain combinations of primers were made and the 
objective of the study was achieved.  
 
In characterization of M. gallisepticum isolates from turkeys, Kleven et al. (2004) 
used primers that resulted in all field isolates in the study forming patterns 
indistinguishable from a vaccine strain 6/85 but clearly different from the other M. 
gallisepticum strains evaluated when an RAPD gel was run. This was 
circumvented by analyzing the isolates with RAPD primer pair OPA13: 5’-
CAGCACCCAC-3’ and OPA14: 5’-TCTGTGCTGG-3’ which resulted in only two 
of the five field isolates generating patterns similar to 6/85. 
 
 
 
 
 
  171.5.4 Amplified Fragment Length Polymorphism (AFLP) 
 
AFLP is a highly sensitive method for detecting polymorphisms in DNA and was 
first described in 1993. The procedure involves digestion of total cellular DNA 
with one or more restriction enzymes and ligation of restriction half-site specific 
adaptors to all restriction fragments, selective amplification of some of these 
fragments with two PCR primers that have corresponding adaptors and 
restriction site specific sequences, as well as electrophoretic separation of 
amplicons on a gel matrix, followed by visualization of a band pattern.  
 
The advantage of this method, as stated by Hong et al. (2005a), is that it requires 
a relatively small amount of DNA and has great discriminatory power and 
reproducibility. This was reported during their study when this method was used 
in differentiation of 44 strains of avian Mycoplasma representing eight different 
species. Restriction enzymes BglII and MfeI were used in the digestion of 
genomic DNA and the MFE1 primer used was modified by adding selective 
nucleotide A at its 3’ end to increase the selectivity of the amplification reaction 
and to obtain better banding pattern resolution.  
 
It was found by the authors that the AFLP analysis provided an optimal 
separation and a uniform sizing of the amplified fragments of between 75 and 
500 bp were used in numerical and cluster analysis for species differentiation and 
resulting in M. gallisepticum showing the highest banding pattern complexity 
consisting of about 90 AFLP fragments while other Mycoplasma species showed 
lower AFLP banding pattern complexity.  
 
Hong et al. (2005a) also used this technique to type 34 strains of M. gallisepticum 
including vaccine strain Ts-11, 6/85 and F. A total of 10 groups with 30 
distinguishable AFLP typing profiles were generated and the method was able to 
identify and differentiate both M. gallisepticum field strains from recent outbreaks 
and those that were epidemiologically related. It was concluded in that study that 
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and also be useful in the evaluation of vaccination programs since it was 
successful in differentiating vaccine strains from other field strains 
 
1.5.5 Pulse-Field Gel Electrophoresis (PFGE)
 
PFGE allows for separation of much larger pieces of DNA than conventional 
agarose gel electrophoresis. In conventional gels, the current is applied in a 
single direction (top to bottom) but in PFGE, the direction of the current is altered 
at a regular interval.  
 
A few studies have been done to evaluate and compare the effectiveness of 
PFGE in Mycoplasma differentiation to other typing techniques. One such study 
was done by Marois et al. (2001) to type 18 strains of M. synoviae. All strains 
analyzed were successfully typed by RAPD but only 89% of the strains could be 
successfully typed by PFGE because of DNA degradation. Although the 
discriminatory power of RAPD was greater than that of PFGE, the two techniques 
had a discrimination index superior to 0.95 which is the threshold value for 
interpreting typing results with confidence.  
 
These results correlate with those reported by Marois et al. (2001) where the two 
techniques were used to compare 21 M. gallisepticum strains and 5 M. imitans 
strains. The discriminatory powers in this study were also superior to 0.95 with a 
reproducibility of 100% for both RAPD and PFGE. It is reported, however, that 
the drawback of RAPD was the inconsistent band intensity complicating the 
interpretation of patterns, while the PFGE limit was its low typeability (86%).  
 
Results outlined in this section make it rational to choose other typing methods 
over PFGE as this technique almost always shows lower effectiveness for typing 
of strains. Also mentioned is the degradation of DNA that takes place when using 
PFGE, further discouraging usage of this method. However, it might be advisable 
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differentiation. 
 
1.6 Previously isolated field strains of M. gallisepticum 
 
A large number of M. gallisepticum strains have been isolated from a wide variety 
of habitats and it is therefore impossible to elaborate on all strains in this review. 
Known strains are mostly used as references during differentiation of field strains. 
MG-ATCC 15302, MG-A5969 and MG-PG31 were used by Marois et al. (2001) 
as reference strains in a study to differentiate between M. gallisepticum and M. 
imitans strains. The origins of these strains are a turkey brain (1958), chicken 
trachea (year not documented) and chicken (1960), respectively.  
 
Other strains that are commonly isolated are K4029 and K4043 that were first 
recovered in 1995 from two commercial turkey flocks in Nebraska, K4421A from 
Michigan in 1997 in turkeys, K4465 isolated in 1997 from turkeys in Ohio and 
K4236 that was isolated in 1997 from commercial turkeys in Virginia (Kleven et 
al., 2004). 
 
In a study by Hong et al. (2005b), 34 M. gallisepticum field strains were used 
from which a dendogram based on the Mgc2 and Random Amplified Polymorphic 
DNA (RAPD) analysis typing was constructed. Using Mgc2 to classify strains, 
strains were placed into 8 groups while the RAPD typing results placed strains 
into 11 groups.  
 
Some field strains may differ very slightly by serology or other aspects, such as 
the subtypes of M. gallisepticum-K4997, which include subtypes starting from 
K4997-S1 through K4997-S10 (up to the latest isolated subtype). Strain K4997-
S10 is a subculture of the vaccine strain 6/85 and K3944 is an isolate from 6/85-
vaccinated turkeys.  
  20Hong et al. (2005a) made a very important observation that strains isolated from 
the same farm are usually typed into the same groups, like the chicken strains 
K4997-S6 and K4997-S5, turkey strains K4997-S7 and K4997-S8, each pair 
isolated from a different farm in North Carolina in 2000. Another strain, MG-S6, 
was used successfully as a control in an experiment by Ferraz and Danelli (2003) 
in differentiation of vaccine strains Ts-11 and 6/85.   
 
1.7 Control and eradication of M. gallisepticum infections 
 
1.7.1 Vaccination 
 
Interest in M. gallisepticum vaccines originated in the late 1970s as it became 
apparent that M. gallisepticum infection was endemic in some multiple-age, egg-
laying complexes (Ley, 2003). Nowadays, vaccination is widely used in 
controlling M. gallisepticum infections in poultry. Vaccines are considered safe if 
they are not virulent to the host to which they are administered, as this could be a 
way of initiating an infection and a possible outbreak.  
 
A disadvantage of currently available M. gallisepticum vaccines is that there is no 
convenient serological technique to accurately distinguish between vaccinated 
and naturally infected flocks (Ferraz & Danelli, 2003). It has been shown 
however, that vaccinated birds are immune to respiratory disease, airsacculitis 
and drops in egg production caused by M. gallisepticum infections and that 
vaccination also results in reduced levels of egg transmissibility of the organism 
in breeders. Both live and inactivated vaccines are used in the vaccination 
programs (OIE). 
 
1.7.1.1 Inactivated vaccines 
 
M. gallisepticum bacterins (killed organisms) are mostly used to protect pullets 
from infection. Bacterins are combined with an oil-emulsion adjuvant and are 
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subcutaneously in the neck. This suspension protected young chickens from 
intrasinus challenge with virulent M. gallisepticum and commercial egg layers 
from M. gallisepticum-induced drops in egg production (Ley, 2003). Other reports 
include protection of broilers and layers, from airsacculitis and reduced egg 
production, respectively, as cited by Ley (2003).  
 
Vaccination with bacterins has been shown to reduce, but not eliminate 
colonization by M. gallisepticum in challenge experiments. Bacterins have been 
reported to be non-advisable in long-term control of infection on multiple-age 
production sites. Furthermore, bacterins are disadvantaged by a need for two 
doses for optimal protection, as well as the cost of individual bird administration. 
To enhance the performance of bacterins, various adjuvants and antigen delivery 
systems, including liposomes and iota carrageenan have been investigated. The 
OIE has reported that bacterins cannot prevent infection from wild-type M. 
gallisepticum. Bacterins are currently commercially produced and available. 
   
1.7.1.2 Live vaccines 
 
The most important live vaccines are MG-F, Ts-11 and 6/85. 
 
1.7.1.2.1 The MG –F vaccine strain 
 
The MG-F strain was first isolated by Yamamoto and Adler, as cited by Ley 
(2003). The authors first described this strain as a typical pathogenic strain. The 
strain has become the most utilized vaccine in preventing the colonization by 
most virulent M. gallisepticum strains (Ferraz & Danelli, 2003). It was further 
reported that the F strain is naturally occurring and has mild to moderate 
virulence in chickens but is virulent in turkeys.  
 
  22The strain spreads slowly from bird to bird and little or no respiratory reaction is 
observed when the strain is administered to healthy chickens via the upper 
respiratory tract, but respiratory signs and airsacculitis may result when 
administered by aerosol or in the presence of other respiratory disease or other 
respiratory disease agents such as Newcastle disease or Infectious Bronchitis 
Virus. The most significant advantage of the F-strain is that vaccinated chickens 
are permanent carriers and therefore a single dose is adequate. 
 
The F strain has been used extensively in multiple-age laying complexes to 
reduce M. gallisepticum-caused egg production losses. In broilers, vaccination 
with this strain provided some protection from airsacculitis following aerosol 
challenge with the virulent R strain. The biological protection by the F strain was 
found not to involve competition for adherence sites or blockage by prior 
colonization and vaccination with the F strain did not prevent colonization by the 
challenge strain of M. gallisepticum. Vaccinated pullets simply maintain the 
organism in the upper respiratory tract for as long as they live. The F strain can 
thence displace the virulent strain until no virulent strains can be detected (Ley, 
2003). This vaccine strain is currently not registered for use in South Africa. 
 
1.7.1.2.2 The Ts-11 and 6/85 vaccine strains 
 
Ts-11 and 6/85 are commercially available as attenuated vaccines and were 
found to be poorly transmitted from vaccinated to unvaccinated birds. The 6/85 
strain originated in the U.S.A and vaccine characteristics were described by 
Evans and Hafez (1992), while the development and characterization of the 
Australia-originated Ts-11 strain was described by Whithear (1990). 
 
In a study by Ferraz & Danelli (2003), the two vaccines showed little or no 
virulence to both chickens and turkeys. Transmission can occur very poorly if 
birds are in very close contact, thus it is safe to say that these vaccines are safer 
than the F-strain. Ley et al. (1997b) discovered that Ts-11 could be detected by 
  23serology via detection of antibodies in vaccinated flocks while 6/85 could not be 
detected using this technique.  
The Ts-11 strain could not be differentiated from the F-strain until Ferraz and 
Danelli (2003) developed polyclonal antibodies to the M. gallisepticum antigens 
produced in chickens used in serological tests to determine antigenic variability. 
The most evident characteristic observed was the specific response of the 
vaccine-type F polyclonal antiserum to the 75 kDa peptide band of the 
homologous strain. It was also reported that this 75 kDa peptide is not present in 
the Ts-11 strain but present in the F-strain as seen in Figure 1.3 below. These 
results therefore show that this homology can be a drawback to the investigator 
in identifying a vaccine strain.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: SDS-PAGE of proteins from Mycoplasma gallisepticum strains. 
Lane1,molecular mass standards (Sigma); Lane 2, MG Ts11/Mycovax Ts-11 vaccine, 
Rhodia-Mericux®;  Lane 3, MG-F/MG-F vaccine, Coopers®; Lane 4, MG-S6 (208)/ 
  24virulent strain. The 75 kDa peptide band is marked in the figure as pb 75 and indicated 
by an arrow. (Ferraz & Danelli, 2003). 
 
 
One of the most desirable properties of a vaccine is the ability to displace virulent 
wild-type strains. Such properties have been fully confirmed in the F strain. 
However, eradication of the live F-strain (Turner & Kleven, 1998) was achieved in 
1994 when the Ts-11 strain was introduced in a commercial layer farm that had 
MG-F positive flocks. M. gallisepticum was isolated from Ts-11 vaccinated flocks 
but no M. gallisepticum could be isolated when vaccination was discontinued and 
also no M. gallisepticum was detected in non-vaccinated birds. After the last 
vaccinated flock was marketed, no M. gallisepticum was detected on the farm 
thus indicating a potential use of Ts-11, after the MG-F strain, for eradication of 
M. gallisepticum. 
 
In other investigations, vaccination with Ts-11 protected broiler breeders and 
their embryos and also allowed better production performance. The vaccine is 
administered by the eye-drop route as a single dose to growing pullets 9 weeks 
of age or older, at least 3 weeks before expected exposure to field challenge. In 
vaccinated flocks, the Ts-11 vaccine strain persists for the life of the flock in the 
upper respiratory tract and induces long-lived immunity (Ley, 2003).  
 
The 6/85 vaccine is administered by spray and results in little or no detectable 
serologic response. The vaccine is detectable in the upper respiratory tract for 4-
8 weeks after vaccination. This vaccine is formulated as a freeze-dried pellet and 
administered as a single dose to pullets 6 weeks of age or older. The vaccine has 
been reported as safe for chickens and has not occurred in unvaccinated flocks. 
 
1.7.1.2.3 Possible M. gallisepticum vaccines 
 
The K5054 strain of M. gallisepticum was isolated from the sinus exudate of a 
commercial turkey flock. The flock did not exhibit the typical clinical signs of M. 
gallisepticum infection (Ferguson et al., 2004). To test the efficacy of K5054, the 
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challenge chickens and turkeys used in the study. It was observed from the study 
that infection with K5054 and Ts-11 did not result in significant clinical signs or 
lesions indicative of M. gallisepticum disease. It could then be concluded that 
these strains are safe vaccines. The K5054 strain was consistently re-isolated 
from the trachea of vaccinated poults and this was indicative of the colonization 
and persistence of the K5054 strain in the upper respiratory tract.   
 
Papazisi et al. (2002) assessed the efficacy of a modified live M. gallisepticum 
vaccine designated GT5 for the protection of chickens against infection and 
respiratory disease. This vaccine was constructed by the reconstitution of the 
avirulent high passage R (Rhigh) strain with the gene encoding GapA, a 
cytadhesin. The organism expressed GapA on its surface, retaining the 
phenotypic characteristics of the parental Rhigh strain. Birds vaccinated with GT5 
were protected upon challenge with the virulent low passage R (Rlow) strain as 
evidenced by the amounts of IgG. Compiled results suggested that the tracheal 
IgG elicited by GT5 vaccination may have been responsible for blocking the initial 
colonization of Rlow, thereby resulting in protection.   
 
1.7.2 Antibiotics  
 
M. gallisepticum has shown sensitivity in vitro and in vivo to several antibiotics 
that act by inhibiting the metabolism of organisms, including macrolides, 
tetracyclines, fluoroquinoles and others; but is resistant to penicillin and other 
antibiotics which act by inhibiting cell wall biosynthesis due to their lack of cell 
walls. It is further reported that M. gallisepticum may develop resistance and 
demonstrate cross-resistance to commonly used antibiotics (Ley, 2003).  
 
A recent study was done by Nascimento et al. (2005a) to evaluate the eradication 
of  M. gallisepticum and  M. synoviae using antimicrobial drugs. Procedures 
included the injection of antibiotics into eggs (via the small end and the air sac 
  26cell), infected chicken as well as day-old chicks. A total of 3 464 hens of a genetic 
stock of white egg fowls (leghorn) were used with age ranging from 45 to 53 
weeks old and a laying production ranging from 37 to 48%.  
 
For the treatment of infected eggs, tylosin and gentamicin sulfate were diluted in 
85% saline and inoculated into each egg. Additionally, each day-old chick 
received a subcutaneous injection containing 0.2 mL of a Linco-Spectin solution 
that also contains 0.05 mL vitamin complex in its composition. It was concluded 
after observation of the results that the antimicrobial egg treatment scheme 
applied with biosecurity measures was sufficient for achieving M. gallisepticum 
and M. synoviae-free chickens with only one application.  
 
Drugs of choice, tylosin and gentamicin, were used because of proven efficacy 
against Mycoplasma and broad-spectrum activity against bacteria respectively, 
the latter also showing low toxicity to host cells. However, tylosin can be toxic for 
embryos at higher doses and this results in drops in the hatchability (Nascimento 
et al., 2005a). 
 
1.8 Closely related Mycoplasma 
 
1.8.1 Mycoplasma imitans 
 
M. imitans type strain 4229T was isolated in France from the turbinate of a duck, 
with airsucculitis and peritonitis (Abdul-Wahab et al., 1996), and was tentatively 
identified as M. gallisepticum by immunofluorescence and growth inhibition tests 
(Harasawa et al., 2004). Using M. gallisepticum  as a reference strain, further 
biochemical and molecular analyses including SDS-PAGE profiles of cellular 
proteins, restriction enzymes cleavage patterns of genomic DNAs, the G+C 
contents, and Southern Blot hybridization using rRNA and tuf gene probes 
supported the observation that M. imitans strains were similar to one another but 
different from the strains of M. gallisepticum.  
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Comparison of the morphological, cultural and physical properties by Bradbury et 
al. (1993) between the type strain MI-4229T and MI-B2/85 demonstrated the 
similarity between these organisms by performing a restriction enzyme analysis 
of their genomic DNA. It was confirmed from the results obtained that both strains 
had phenotypic properties very similar to M. gallisepticum including the presence 
of an attachment organelle. Therefore, in essence, the “imitans” in M. imitans 
meaning “imitate”, is derived from observations that this organism is very similar 
to M. gallisepticum in many ways.  
 
Markham et al. (1999) reported that of the other Mycoplasma in the pnuemoniae 
group,  M. gallisepticum is closest related to M. imitans according to the 16S 
rRNA gene analysis. Further results correlated to this, as the oligo 1 probe which 
was complementary to the GAA repeat sequence associated with pMGA genes 
in M. gallisepticum bound multiple bands in Southern blots of M. gallisepticum 
and M. imitans genomic DNA digested with EcoRI or BglII, but did not bind to 
genomic fragments of the other Mycoplasma species in the pneumoniae-group. 
Using antigenic analysis, rabbit anti-pMGA antisera reacted with a band of       
approximately 67 kDa in Western blot of M. gallisepticum proteins and with a 
single band of approximately 35 kDa in M. imitans but not with any proteins of 
other Mycoplasma species (Markham et al., 1999). 
 
M. imitans causes ciliostasis in chicken and duck tracheal organ cultures and has 
an adherence structure similar to that present in M. gallisepticum. The organism 
produces respiratory disease similar but somewhat milder than M. gallisepticum 
in red-legged patridges. M. imitans does not produce signs or lesions when 
inoculated into chickens, but in a dual infection with Infectious Bronchitis virus, a 
synergistic effect was observed (Ley, 2003). The threat underlying M. imitans 
identification is the possible misidentification of isolates as M. gallisepticum and 
possible serologic cross-reactions in testing of field flocks. 
 
  281.8.2 Other avian Mycoplasma pathogens   
 
The importance of gathering information of other related Mycoplasma species is 
due to the fact that these related species may, in one way or another be detected 
from the field. Knowing the background information of these species may aid in 
identification and species differentiation. Detection of these species could be 
when e.g.: universal Mycoplasma primers are used in a PCR assay. The other 
importance is due to the similarity of symptoms and clinical signs in the host that 
may be misinterpreted as those of M. gallisepticum. A few of these avian 
Mycoplasma are included in this review: 
 
1.8.2.1 Mycoplasma meleagridis 
 
M. meleagridis is a specific pathogen of turkeys. The organism causes egg-
transmitted disease in which the primary lesion is an airsacculitis in the progeny. 
Other manifestations include decreased hatchability, skeletal abnormalities and 
poor growth performance. Broth cultures of M. meleagridis are similar to those of 
M. gallisepticum.  
 
Ultrastructure studies of the cells showed that M. meleagridis does not have a tip-
organelle typical of M. gallisepticum but has thicker fibrils in the central nuclear 
area. In both species, ribosomes are distributed in uniform rings around the cell 
peripheries.  M. meleagridis is facultatively anaerobic with optimal growth at 37-
38 °C and slight growth at 40-42 °C. With regards to antigenicity, M. meleagridis 
is unrelated to all other avian Mycoplasma species (Chin et al., 2003).   
 
 
1.8.2.2 Mycoplasma synoviae 
 
M. synoviae infection most frequently occurs as subclinical upper respiratory 
infection that leads to infectious synovitis. It may cause air sac lesions when 
  29combined with Newcastle disease (ND), Infectious bronchitis (IB), or both. 
Nicotinamide adenine dinucleotide (NAD) is required for growth.  
 
Cells appear as pleomorphic coccoid bodies of approximately 0.2 µm in 
diameter. The optimum temperature for growth is 37 °C and growth is best 
observed on agar if the plates are enclosed in an air-tight container (Kleven, 
2003). 
 
  
1.8.2.3 Mycoplasma iowae 
   
M. iowae has been associated with reduced hatchability and embryo death in 
turkeys. The organism has also been shown to induce mortality in turkey and 
chicken embryos. Mild to moderate airsacculitis and leg abnormalities in chickens 
and turkeys have also been observed. Poult hatchability can be reduced by 2-5 
%. Growth requirements are similar to those of other Mycoplasma but most 
importantly, an attachment organelle (as in M. gallisepticum) has been reported 
(Bradbury and Kleven, 2003).  
 
1.8.2.4 Mycoplasma gallinarum and Mycoplasma gallinaceum 
 
These species have not been considered to be pathogenic, however isolation 
has been possible from infected poults. These organisms are usually 
contaminants when isolation of M. gallisepticum or M. synoviae is attempted. M. 
gallinarum is primarily isolated from chickens but it may also be found in turkeys 
(Hong et al., 2005a; Kleven, 2003). 
 
1.9 Avian Ureaplasma  
 
Ureaplasmas fall in the same class as Mycoplasma but differ from Mycoplasma 
primarily in their ability to hydrolyze urea. Very little is known about their 
  30pathogenicity. Artificial challenge of chickens produced no clinical signs or 
macroscopic lesions. However, turkeys and chickens challenged with a turkey 
Ureaplasma developed fibrinous airsacculitis and serological responses. 
Ureaplasmas have further been isolated from turkeys that were experiencing 
problems with reduced fertility (Kleven, 2003). 
 
1.10 Conclusions 
 
M. gallisepticum continues to be a major problem in the poultry industry. Flock 
monitoring is essential in detection and quantification of infection. Though useful 
and rapid, serological techniques are limited in their ability to classify infection as 
well as to establish if the flock is vaccinated or infected with the wild-type strain. 
An added advantage of serological methods is that many of these techniques can 
be performed at the site of infection by designated employees. Examples include 
commercially available antigens. 
 
Molecular techniques have been repeatedly shown to be more useful than 
serological techniques in strain detection and differentiation. The drawbacks with 
molecular techniques, however, are the costs involved as well as the expertise 
that the investigator must have.  
 
Vaccination has been proven to be the best method in controlling M. 
gallisepticum infection by increasing immunity of the poults against infection. The 
F-strain, which is currently not registered for use in South Africa, is said to be the 
most efficient vaccine strain for protection. The Ts-11 strain is also an efficient 
vaccine strain but should be maintained specifically under stipulated temperature 
due to its sensitivity to high temperature. The third most widely used strain is the 
MG-6/85. This strain is not as effective as the MG-F and MG-Ts-11 strains and 
does not provide adequate protection. 
 
  31Furthermore, vaccination is a good alternative to antibiotic administration. 
Besides the toxicity of antibiotics, it is a known fact that microbes can develop 
resistance to antibiotics. This further leads to very limited number of antibiotics 
left that can be used and there is additional pressure to produce new antibiotics. 
The problem becomes continuous when microbes acquire resistance to these 
newly synthesized antibiotics.  
 
Other studies were conducted to investigate differences between vaccine strains 
themselves. A band-difference found in the SDS-PAGE profiles of the MG-Ts-11 
and the MG-F strains could be the cause of the antigenic variability between 
these strains. The band is present in the F strain but not in the Ts-11 strain, 
which can be hypothesized as responsible for the pathogenicity of the F-strain in 
turkeys but not in chickens. 
 
During the process of pathogenesis, cytadhesins play an important role as 
mediators. In addition to this, they can also be used in both species and strain 
differentiation. These proteins display high homology in M. gallisepticum as well 
as some homology to cytadhesins of other Mycoplasma, including human 
pathogenic  Mycoplasma. To date, no M. gallisepticum infection has been 
reported in humans. There is however, possibility of such a scenario due to the 
homology of the cytadhesins as well as the fact that like human Mycoplasma, M. 
gallisepticum is invasive to the target host cells.    
 
Previous studies that evaluated differentiation have demonstrated that isolates 
from the same farms are usually the same strains, if not closely related. Isolated 
farms in the same geographical area will also have different isolates though with 
similar characteristics. This is an indication that, the biological properties of 
organisms can be altered by their environmental conditions and can therefore 
conform to the same requirements.  
 
  32M. imitans is the most closely related avian Mycoplasma to M. gallisepticum and 
has, in many cases, been misidentified as M. gallisepticum. These organisms are 
serologically cross-reactive and therefore even harder to differentiate. In addition 
to the high serological relatedness, molecular relatedness is also significant. 
Findings are always more accurate if a system has been developed to fully 
differentiate between M. gallisepticum and M. imitans.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  33CHAPTER 2 
 
INTRODUCTION INTO THE PRESENT STUDY. 
 
 
The literature has always indicated that Mycoplasma gallisepticum is a 
continuous problem in the poultry industry, leading to economic losses worldwide 
(Ferguson et al., 2004). An M. gallisepticum-infected chicken lays 15.7 less eggs 
than a healthy one (Nascimento et al., 2005b). These reductions led to the loss of 
127 millions eggs in the USA in 1984. A similar survey was conducted in Brazil 
ten years later and it was found that respiratory disease caused by M. 
gallisepticum had led to a loss of 34 thousand tons of broilers.  
 
Surveys have continued to be conducted and characterization of the organism 
done in different geographical areas. No such information has been documented 
for South African incidences; therefore the diversity of the organism is not known.   
Work done by Hong et al. (2005a) indicated that M. gallisepticum isolates differed 
from farm to farm in the same geographical area. South Africa represents a 
different geographical area on its own, therefore giving scope for the diversity of 
the organism among strains in the country and also different from those from 
other countries.  
 
Serological tests performed in Southern African farms have been found to give 
positive results and in some cases classical M. gallisepticum symptoms are 
observed. Various tests performed on isolates have indicated that there is a 
different type of M. gallisepticum in South Africa when compared to standards 
set-up according to previously isolated M. gallisepticum. Furthermore, it is 
important to note that it is not clearly known if the vaccine strain MG-F, reportedly 
the most effective and currently not registered for use in South Africa, is indeed 
absent in the field. The strain is naturally-occurring in the USA and can sustain 
viability in the host.  
  34The stated lack of information on the different aspects of M. gallisepticum led to 
the objectives of this study which were to firstly investigate the presence of this 
organism in Southern Africa. Detection would be evaluated using PCR assays 
that would be optimized so as to ensure adequate detection. Using the 
technique, differentiation of the isolates would begin at this level by construction 
of  M. gallisepticum-specific assays as well as an assay that can also detect 
closely related species. 
 
The second objective of the study was to accurately identify the detected isolates 
as well as to establish their origin. This would then establish whether the strains 
are endemic to Southern Africa or not. RFLP patterns of these strains were 
examined and therefore gave an indication of the diversity among these strains. 
Furthermore, it was investigated whether the isolates were M. gallisepticum or M. 
imitans. The clinical history of the flocks from which the strains were isolated was 
compared to the findings of this study and a correlation was investigated. 
 
The final objective of the study focused on constructing a phylogenic tree as this 
would give an indication of whether isolates from the same area were indeed 
closer in lineage than to those isolated from a different geographical area. If other 
organisms, other than M. gallisepticum, were isolated using the same 
parameters, the tree would indicate the relatedness of such organisms to M. 
gallisepticum. 
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PCR detection and RFLP analyses of M. gallisepticum isolates from poultry 
productions in Southern Africa. 
    
 
3.1 Introduction  
 
Reference to Papazisi et al. (2003) was made in the first chapter. The authors 
completed sequencing of the genome of M. gallisepticum. It was also mentioned 
that some genes are conserved while others are not. Such information provides 
an added advantage during differentiation, particularly when the PCR assay is 
being investigated.  
 
Conserved genes are usually targeted when members of a certain genus are to 
be detected. This may also be limited to only closely related organisms. Species-
specific genes are targeted when only a specific species of organism is 
investigated. In most cases the rRNA genes are targeted when a broad variety of 
related organisms is investigated. 
 
In  M. gallisepticum investigations, it is advisable to target cytadhesins in 
increasing specificity. Though homologous in Mycoplasma species, cytadhesins 
are quite species-specific. Nucleotides sequences of chosen genes are obtained 
from Genbank and primers complementary to that sequence are designed.  
 
Though an effective technique, PCR can have certain limitations. This was 
observed by Mekkes and Feberwee (2005) when using real-time PCR. It was 
found that though differentiation was achieved between M. gallisepticum and 
other avian Mycoplasma such as M. synoviae and M. meleagridis, M. imitans 
could not be distinguished from M. gallisepticum. 
 
  36Harasawa and co-workers (2004) identified an insertion sequence which is 
present in the intergenic transcribed spacer (ITS) region of M. imitans. This was 
confirmed by utilizing a PCR assay which further indicated the size-difference of 
this sequence in the ITS region of M. gallisepticum when compared to that of M. 
imitans. When products were being viewed on an agarose gel, the size-difference 
played an important role in discrimination of M. imitans from M. gallisepticum. 
Though a small number of isolates was used in this study, the consistency of the 
results obtained reassures the reliability of the assay. 
 
Following PCR assays, RFLP profiles can further confirm differences in isolates. 
Restriction maps drawn for different isolates may produce differences based on 
which enzymes do recognize their designated restriction sites. This can be used 
to explain the fact that PCR products from different isolates may be subjected to 
the same enzymes from which products can be used to confirm the presence or 
absence of homology. 
 
3.2 Objectives  
 
This section was aimed at the development of a sensitive PCR assay that could 
be used to detect M. gallisepticum isolates at the 16S rRNA gene as well as to 
target an M. gallisepticum-specific gene in attempt to differentiate this organism 
from related organisms. An additional aim was to target an M. imitans-specific 
gene so as to establish the presence of this organism that is extremely similar to 
and often hard to distinguish from M. gallisepticum. 
 
3.3 Materials and methods 
 
The materials used were obtained from Southern Cross Biotechnology (PTY) 
LTD.:  QIAamp® DNA mini kit, SuperTherm DNA polymerase (Taq); 
Separations: Agarose D-1 Low EEO; Whitehead Scientific (PTY) LTD: Low 
Melt Agarose # L-M Seive; Biolabs:  PCR ThermoPol Buffer; Fermentas: 
  37O’GeneRuler™ 100 bp DNA ladder mix, O’GeneRuler™ Loading dye solution, 
O’GeneRuler™ 50 bp DNA ladder, MvaI 2691 (BsmI), PstI, Buffer R; Amersham 
Biosciences: GFX™ PCR DNA and Gel band Purification Kit; Merial South 
Africa:  Live attenuated Mycoplasma gallisepticum Ts-11 vaccine; Inqaba 
Biotech: All syntheses of primers. 
 
3.3.1 Collection of samples 
 
Samples were collected from serologically M. gallisepticum-positive flocks from 
various farms in South Africa and Zimbabwe. Samples were collected in the form 
of swabs from the trachea of positive flocks.   
 
3.3.2 Extraction of DNA 
 
DNA was extracted following the Qiagen QIAamp® DNA Mini Kit protocol. Elution 
of DNA was carried out at room temperature using the elution buffer provided in 
the kit. Extracted DNA was frozen and stored at -20 
0C until needed. 
 
3.3.3 Positive control  
 
The MG-Ts-11 strain was used as the positive control. Cells were obtained from 
a commercial vaccine solution and genomic DNA was extracted following the 
Qiagen QIAamp® DNA Mini Kit protocol. Elution of DNA was carried out at room 
temperature using the elution buffer provided in the kit. Extracted DNA was 
frozen and stored at -20 
0C until needed. 
 
3.3.4 PCR assays 
 
PCR assays were carried out based on the genes targeted and melting 
temperatures (Tm) of the primers designed.  
 
  383.3.4.1 Amplification of the selected genes 
 
3.3.4.1.1 Amplification of the 16S rRNA gene  
 
Primers complementary to the 16S rRNA gene of M. gallisepticum were designed 
and designated LMGF and LMGR as shown in Table 3.1 below. These primers 
were designed to detect both M. gallisepticum and very closely related 
Mycoplasma particularly M. imitans, as it is the closest in relation to M. 
gallisepticum. Figure 3.1 indicates the expected product of M. gallisepticum and 
its homology to M. imitans which is also expected to be detected. The arrows 
indicate the positions of the primers. All alignments were done at: , unless stated 
otherwise. 
 
 
MG              TTTTCTGAGAGTTTGATCCTGGCTCAGGATTAACGCTGGCGGCATGCCTAATACATGCAA 60 
MI              ---------------------------GATTAACGCTGGCGGCATGCCTAATACATGCAA 33 
                                           ********************************* 
 
MG              GTCGATCGGATGTAGCAATACATTAGAGGCGAACGGGTGAGTAACACGTATCCAATCTGC 120 
MI              GTCGATCGGATGTAGCAATACATTAGAGGCGAACGGGTGAGTAACACGTATCCAATCTGC 93 
                ************************************************************ 
 
MG              CTTATAGTGGGGGATAACTAGTCGAAAGATTAGCTAATACCGCATAACAAGTTAACTATC 180 
MI              CTTATAGTGGGGGATAACTAGTCGAAAGATTAGCTAATACCGCATAACAAGTTACCTATC 153 
                ****************************************************** ***** 
 
MG              GCATGAGAATAACTTTAAAGAAGCAACTGCTTCGCTATAAGATGAGGGTGCGGCATATCA 240 
MI              GCATGAGAATAACTTTAAAGAAGCAACTGCTTCGCTATAAGATGAGGGTGCGGCATATCA 213 
                ************************************************************ 
 
MG              GCTAGTTGGTGAGGATAATGGCCCACCAAGGCGATGACGTGTAGTTATGCTGAGAGGTAG 300 
MI              GCTAGTTGGTGAGGGTAATGGCCCACCAAGGCGATGACGTGTAGTTATGCTGAGAGGTAG 273 
                ************** ********************************************* 
 
MG              AATAACCACAATGGGACTGAGACACGGCCCATACTCCTACGGGAGGCAGCAGTAGGGAAT 360 
MI              AATAACCACAATGGGACTGAGACACGGCCCATACTCCTACGGGAGGCAGCAGTAGGGAAT 333 
                ************************************************************ 
 
MG              TTTTCACAATGGACGAAAGTCTGATGGAGCAATGCCGCGTGAACGATGAAGGTCTTTTTA 420 
MI              TTTTCACAATGGACGAAAGTCTGATGGAGCAATGCCGCGTGAACGATGAAGGTCTTTTTA 393 
                ************************************************************ 
 
MG              GATTGTAAAGTTCTTTTATTTGGGAAGAACAGTTAATAGAGTGGAAAGCTATTAATTTGA 480 
MI              GATTGTAAAGTTCTTTTATTTGGGAAGAACAGTTAGTAGAGTGGAAAGCTACTAATTTGA 453 
                *********************************** *************** ******** 
 
MG              CTGTACCATTTGAATAAGTAACGACTAACTATGTGCCAGCAGTCGCGGTAATACATAGGT 540 
MI              CTGTACCATTTGAATAAGTAACGACTAACTATGTGCCAGCAGTCGCGGTAATACATAGGT 513 
                ************************************************************ 
 
MG              TGCAAGCGTTATCCGGATTTATTGGGCGTAAAACAAGCGCAGGCGGATTAGAAAGTCTGG 600 
MI              TGCAAGCGTTATCCGGATTTATTGGGCGTAAAACAAGCGCAGGCGGATTAGAAAGTCTGG 573 
                ************************************************************ 
 
  39MG              TGTTAAAAGCAATTGCTTAACGATTGTATGCATTGGAAACTTCTAGTCTAGAGTTTGGTA 660 
MI              TGTTAAAAGCAATTGCTTAACGATTGTATGCATTGGAAACTTCTAGTCTAGAGTTTGGTA 633 
                ************************************************************ 
 
MG              GAGAGTCCTGGAACTCCATGTGGAGCGGTGAAATGCGTAGATATATGGAAGAACACCAGA 720 
MI              GAGAGTCCTGGAACTCCATGTGGAGCGGTGAAATGCGTAGATATATGGAAGAACACCAGA 693 
                ************************************************************ 
 
MG              GGCGAAGGCGAGGACTTGGGCCAATACTGACGCTTAGGCTTGAAAGTGTGGGGAGCAAAT 780 
MI              GGCGAAGGCGAGGACTTGGGCCAATACTGACGCTTAGGCTTGAAAGTGTGGGGAGCAAAT 753 
                ************************************************************ 
 
MG              AGGATTAGATACCCTAGTAGTCCACACTGTAAACGATGGATGTTAAGTGTCGGAGCGAAT 840 
MI              AGGATTAGATACCCTAGTAGTCCACACTGTAAACGATGGATGTTAAGTGTCGGAGCGAAT 813 
                ************************************************************ 
 
MG              ACTTCGGTGCTGCAGTTAACACATTAAACATCCTGCCTGAGTAGTACATTCGCAAGAATG 900 
MI              ACTTCGGTGCTGCAGTTAACACATTAAACATCCTGCCTGAGTAGTACATTCGCAAGAATG 873 
                ************************************************************ 
 
MG              AAACTCAAACGGAATTGACGGGGACCCGCACAAGTGGTGGAGCATGTTGCTTAATTCGAC 960 
MI              AAACTCAAACGGAATTGACGGGGACCCGCACAAGTGGTGGAGCATGTTGCTTAATTCGAC 933 
                ************************************************************ 
 
MG              GGTACACGAAAAACCTTACCTAGACTTGACATCTTGGGCGAAGCTATAGAAATATAGTGG 1020 
MI              GGTACACGAAAAACCTTACCTAGACTTGACATCTTGGGCGAAGCTATAGAAATATAGTGG 993 
                ************************************************************ 
 
MG              AGGTCAACCCAATGACAGGTGGTGCATGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGG 1080 
MI              AGGTCAACCCAATGACAGGTGGTGCATGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGG 1053 
                ************************************************************ 
 
MG              TTAAGTCCCGCAACGAGCGCAACCCTTATCGTTAGTTACTTTGTCTAACGAGACTGCCAA 1140 
MI              TTAAGTCCCGCAACGAGCGCAACCCTTATCGTTAGTTACTTTGTCTAACGAGACTGCCAA 1113 
                ************************************************************ 
     
MG              CGTAAGTTGGAGGAAGGTGGGGATGACGTCAAATCATCATGCCCCTTATGTCTAGGGCTG 1200 
MI              CGTAAGTTGGAGGAAGGTGGGGATGACGTCAAATCATCATGCCCCTTATGTCTAGGGCTG 1173 
                ************************************************************ 
 
MG              CAAACGTGCTACAATGGCCAATACAATCAGTTGCAAATCCGTAAGGTGGAGCTAATCTGT 1260 
MI              CAAACGTGCTACAATGGCCAATACAAACAGTTGCAAATCCGTAAGGTGGAGCTAATCTGT 1233 
                ************************** ********************************* 
 
MG              AAAGTTGGTCTCAGTTCGGATTGAGGGCTGCAATTCGCCCTCATGAAGTCGGAATCACTA 1320 
MI              AAAGTTGGTCTCAGTTCGGATTGAGGGCTGCAATTCGCCCTCATGAAGTCGGAATCACTA 1293 
                ************************************************************ 
 
MG              GTAATCGCGAATCAGCCATGTCGCGGTGAATACGTTCTCGGGTCTTGTACACACCGCCCG 1380 
MI              GTAATCGCGAATCAGCCATGTCGCGGTGAATACGTTCTCGGGTCTTGTACACACCGCCCG 1353 
                ************************************************************ 
 
MG              TCAAACTATGAGAGCTGGTAATATCTAAAACCGTGTTGCTAACCGCAAGGAAGCGCATGT 1440 
MI              TCAAACTATGAGAGCTGGTAATATCTAAAACCGTGTTGCTAACCGCAAGGAAGCGCATGT 1413 
                ************************************************************ 
 
MG              CTAGGGTAGGGCCGGTGATTGGAGTTAAGTCGTAACAAGGTACCCCTACGAGAACGTGGG 1500 
MI              CTAGGGTAGGGCCGGTGATTGGAGTT---------------------------------- 1439 
                **************************                                   
 
MG              GGTGGATTACCTCCTTTCT 1519 
MI              ------------------- 
 
Figure 3.1: Alignment of the M. gallisepticum and M. imitans 16S rRNA gene. The 
arrows indicate the positions of the forward and reverse primers.  
 
 
 
  403.3.4.1.2 Amplification of the Mgc2 gene  
 
Primers complementary to the Mgc2 gene of M. gallisepticum were designed and 
designated LMMF and LMMR as shown in Table 3.1 below. Figure 3.2 is an 
illustration of the alignment of the Mgc2 gene sequences in 10 reference strains 
of M. gallisepticum. 
 
3.3.4.1.3 Amplification of a gene encoding an M. imitans hypothetical protein. 
 
Primers complementary to the M. imitans ATPase (soj) hypothetical protein and 
DnaA (dnaA) genes were designed and designated LMPF and LMPG as shown 
in Table 3.1 below. One set of primers was designed to target the sequences of 
both these genes.  
 
Table 3.1: Primer sequences with their respective target genes, approximate amplicons 
sizes and melting temperatures (Tm). 
 Primer     Sequence                                            Target gene        Amplicon size   Tm 
                                                                                                                 (bp)           (
0C)  
LMGF     5’-TGCCAGCAGTCGCGGTAATACATA-3’    16S rRNA                579               64.57 
LMGR     5’-TGCGGGACTTAACCCAACATCTCA-3’                          64.57 
LMMF    5’-TTTTACCCAGTAGTGGGTGCAG-3’             Mgc2                       615               62.67 
LMMR    5’-GTGATTAAACCCACCTCCAGC-3’                                                                    62.57 
LMPF     5’-GTGCCGATTTGGATGACGAAGTTG-3’        ATPase/dnaA        292     64.57 
LMPR     5’-GGTTCTTGCCCTATTATTTCAAGACTACTG-3’         64.63 
 
 
hf51 mgc2   1   TTTTATCCAGTAGTGGGTGCAGGTGCTGGGTTGATTGTTGTTTCTTTACTCTTGGGTTTAGG 62 
r mgc2      1   TTTTATCCAGTAGTGGGTGCAGGTGCTGGGTTGATTGTTGTTTCTTTACTCTTGGGTTTAGG 62 
s6 mgc2     1   TTTTACCCAGTAGTGGGCGCAGGTGCTGGGTTGATTGTTGTTTCTTTACTCTTGGGTTTAGG 62 
a5969 mgc2  1   TTTTACCCAGTAGTGGGCGCAGGTGCTGGGTTGATTGTTGTTTCTTTACTCTTGGGTTTAGG 62 
ts 11 mgc2  1   TTTTATCCAGTAGTGGGTGCAGGTGCTGGGTTGATTGTTGTTTCTTTACTCTTGGGTTTAGG 62 
685 mgc2    1   TTTTATCCAGTAGTGGGTGCAGGTGCTGGGTTGATTGTTGTTTCTTTACTCTTGGGTTTAGG 62 
k730 mgc2   1   TTTTACCCAGTAGTGGGTGCAGGTGCTGGGTTGATTGTTGTTTCTTTACTCTTGGGTTTAGG 62 
f mgc2      1   TTTTACCCAGTAGTGGGTGCAGGTGCTGGGTTGATCGTTGTTTCTTTACTCTTGGGTTTAGG 62 
k703 mgc2   1   TTTTACCCAGTAGTGGGTGCAGGTGCTGGGTTGATTGTTGTTTCTTTACTCTTGGGTTTAGG 62 
k503 mgc2   1   TTTTACCCAGTAGTGGGTGCAGGTGCTGGGTTGATTGTTGTTTCTTTACTCTTGGGTTTAGG 62 
 
hf51 mgc2   63  GATTGGGATTCCGATCGCTAAGAAAAAAGAAAGAATGATGATCCAAGAACGTGAAGAACACC 124 
r mgc2      63  GATTGGGATTCCGATCGCTAAGAAAAAAGAAAGAATGATGATCCAAGAACGTGAAGAACACC 124 
s6 mgc2     63  GATTGGGATTCCGATCGCTAAGAAAAAAGAAAGAATGATGATCCAAGAACGTGAAGAACACC 124 
a5969 mgc2  63  GATTGGGATTCCGATCGCTAAGAAAAAAGAAAGAATGATGATCCAAGAACGTGAAGAACACC 124 
ts 11 mgc2  63  GATTGGGATTCCGATCGCTAAGAAAAAAGAAAGAATGATGATCCAAGAACGTGAAGAACACC 124 
685 mgc2    63  GATTGGGATTCCGATCGCTAAGAAAAAAGAAAGAATGATGATCCAAGAACGTGAAGAACACC 124 
  41k730 mgc2   63  GATTGGGATTCCGATCGCTAAGAAAAAAGAAAGAATGATGATCCAAGAACGTGAAGAACACC 124 
f mgc2      63  GATTGGGATTCCGATCGCTAAGAAAAAAGAAAGAATGATGATCCAAGAACGTGAAGAACACC 124 
k703 mgc2   63  GATTGGGATTCCGATCGCTAAGAAAAAAGAAAGAATGATGATCCAAGAACGTGAAGAACACC 124 
k503 mgc2   63  GATTGGGATTCCGATCGCTAAGAAAAAAGAAAGAATGATGATCCAAGAACGTGAAGAACACC 124 
 
hf51 mgc2   125 AAAAGATGGTTGAATCCCTTGGAATAATTGAAGAACAAAATAAAACAGAAGCGATTGAGCCA 186 
r mgc2      125 AAAAGATGGTTGAATCCCTTGGAATAATTGAAGAACAAAATAAAACAGAAGCGATTGAGCCA 186 
s6 mgc2     125 AAAAGATGGTTGAATCCCTTGGTATAATCGAAGAACAAAATAAAACAGAAGCGATTGAGCCA 186 
a5969 mgc2  125 AAAAGATGGTTGAATCCCTTGGTATAATCGAAGAACAAAATAAAACAGAAGCGATTGAGCCA 186 
ts 11 mgc2  125 AAAAGATGGTTGAATCCCTTGGAATAATCGAAGAACAAAATAAAACAGAAGCGATTGAGCCA 186 
685 mgc2    125 AAAAGATGGTTGAATCCCTTGGAATAATCGAACAACAAAATAAAACAGAAGCGATTGAATCA 186 
k730 mgc2   125 AAAAGATGGTTGAATCCCTTGGAATAATCGAGCAACAAAATAAAACAGAAGCGATTGAGTCA 186 
f mgc2      125 AAAAGATGGTTGAATCCCTTGGAATAATCGAGCAACAAAATAAAACAGAAGCGATTGAGTCA 186 
k703 mgc2   125 AAAAGATGGTTGAATCCCTTGGAATAATCGAGCAACAAAATAAATCAGAAGCGATTGAGTCA 186 
k503 mgc2   125 AAAAGATGGTTGAATCCCTTGGAATAATTGAACAACAAAATAAAACAGAAGCGATTGAGTCA 186 
 
hf51 mgc2   187 ACTGCAGCAGTGCCAACTGAAGAAGTTAATACTCAAGAACCAACTCAACCAGCTGGTGTTAA 248 
r mgc2      187 ACTG---------------AAGAAGTTAATACTCAAGAACCAACTCAACCAGCTGGTGTTAA 233 
s6 mgc2     187 ACTGCAGCAGTGCCAACTGAAGAAGTTAATACTCAAGAACCAACTCAACCAGCTGGTGTTAA 248 
a5969 mgc2  187 ACTGCAGCAGTGCCAACTGAAGAAGTTAATACTCAAGAACCAACTCAACCAGCTGGTGTTAA 248 
ts 11 mgc2  187 ACTACATCAGTGCCAACTGAAGAAGTTAATACTCAAGAACCAACTCAACCAGCTGGTGTTAA 248 
685 mgc2    187 ACTGCAGCAGTGCCAACTGAAGAAGTTAATACTCAAGAACCAACTCAACCAGCTGGTGTTAA 248 
k730 mgc2   187 ACCACAGCAGTACCAACTGAAGAAGTTAATGTTCAAGAACCAACTCAACCAGCTGATGTAAA 248 
f mgc2      187 ACCACAGCAGTACCAACTGAAGAAGTTAATGTTCAAGAACCAACTCAACCAGCTGATGTAAA 248 
k703 mgc2   187 ACCACAGCAGTACCAACTGAAGAAGTTAATGTTCAAGAACCAACTCAACCAGCTGATGTAAA 248 
k503 mgc2   187 ACCACAGCAGTACCAACTGAAGAAGTTAATGTTCAAGAACCAACTCAACCAGCTGATGTAAA 248 
 
hf51 mgc2   249 TGTAGCTAATAACCCTCAGATAGGGATCAATCAACCAGGATTTAATCAACCTCAGATTAATC 310 
r mgc2      234 TGTAGCTAATAACCCTCAGATGGGGATCAATCAACC---------------TCAGATTAATC 280 
s6 mgc2     249 TGTAGCTAATAACCCTCAGATGGGGATCAATCAACCAGGATTTAATCAACCTCAGATTAATC 310 
a5969 mgc2  249 TGTAGCTAATAACCCTCAGATGGGGATCAATCAACCAGGATTTAATCAACCTCAGATTAATC 310 
ts 11 mgc2  249 TGTAGATAATAACCCTCAGATGGGGATCAATCAGCCAGGATTTAATCAACCTCAGATTAATC 310 
685 mgc2    249 TGTAGATAATAATCCTCAGATGGGGATCAATCAGCCAGGATTTAATCAACCTCAGATTAATC 310 
k730 mgc2   249 TGTAGCTAATAATCCTCAGATGAGGATCAATCAACCAGGATTTAATCAACCTCAGATCAATC 310 
f mgc2      249 TGTAGTTAATAATCCTCAGATGGGGATCAATCAACCAGGATTTAATCAACCTCAGATCAATC 310 
k703 mgc2   249 TGTAGCTAATAATCCTCAGATGGGGATCAATCAACCAGGATTTAATCAACCTCAGATCAATC 310 
k503 mgc2   249 TGTAGCTAATAATCCTCAGATGGGGATCAATCAACCAGGATTTAATCAACCTCAGATCAATC 310 
 
hf51 mgc2   311 CGCAATTTGGTCCTAATCCCCAACAAAGAATTAACCCACAGGGCTTTGGTGGCCCAATGCCA 372 
r mgc2      281 CGCAATTTGGTCCTAATCCCCAACAAAGAATTAACCCACAGTGCTTTGGTGGCCCAATGCAA 342 
s6 mgc2     311 CGCAATTTGGTCCTAATCCCCAACAAAGAATTAACCCACAGGGCTTTGGTGGCCCAATGCCA 372 
a5969 mgc2  311 CGCAATTTGGTCCTAATCCCCAACAAAGAATTAACCCACAGGGCTTTGGTGGCCCAATGCCA 372 
ts 11 mgc2  311 CGCAATTTATTCCTAATCCCCAACAAAGAATGAACCCACAGGGCTTTGGTGGCCCAATGCCA 372 
685 mgc2    311 CGCAATTTGGTCCTCATCCCCAACAAAGAATTAACCCGCAGGGCTTTGGTGGCCCAATGT-- 370 
k730 mgc2   311 CACAATTTGGTCTTAATCCCCAACAAAGAATTAATCCACAGGGTTTTGGTGGCCTAATTCCA 372 
f mgc2      311 CACAATTCGGTCTTAATCCCCAACAAAGAATTAATCCACAGGGTTTTGGTGGCCCAATGCCA 372 
k703 mgc2   311 CACAATTTGGTCTTAATCCCCAACAAAAAATTAATCCACAGGGTTTTGGTGGCCCAATGCCA 372 
k503 mgc2   311 CACAATTTGGTCTTAATCCCCAACAAAGAATTAATCCACAGGGTTTTGGTGGCCCAATGCCA 372 
 
hf51 mgc2   373 CCTAACCAAATGGGAATGCGACCAGGGTTTAACCAAATGCCCCCACAAATGGGAGGAATGCC 434 
r mgc2      343 CCTAACCAAATGGGAATGCGACCAGGGTTTAACCAAATGCCCCCACAAATGGGAGGAATGCC 404 
s6 mgc2     373 CCTAACCAAATGGGAATGCGACCAGGGTTTAACCAAATGCCCCCACAAATGGGAGGAATGCC 434 
a5969 mgc2  373 CCTAACCAAATGGGAATGCGACCAGGGTTTAACCAAATGCCCCCACAAATGGGAGGAATGCC 434 
ts 11 mgc2  373 CTTAACCAAATGGGGATGCGACCAGGGTTTAACCAAATGCCCCCACAAATGGGAGGAATGCC 434 
685 mgc2    371 -------------------------------------------------------------C 371 
k730 mgc2   373 CCTAACCACATGGGGATGCGACCAGGGTTTAACCAAATGCCGCCACAGATGGGTGGGATGCC 434 
f mgc2      373 CCTAACCACATGGGGATGCGGCCAGGGTTTAACCAAATGCCGCCACAAATGGGTGGGATGCC 434 
k703 mgc2   373 CCTAACCACATGGGGATGCGACCAGGGTTCAACCAAATGCCGCCACAGGTGGGTGGGATGCC 434 
k503 mgc2   373 CCTAACCACATGGGGATGCGGCCAGGGTTTAACCAAATGCCGACACAGATGGGTGGGATGCC 434 
 
hf51 mgc2   435 ACCTAACCAAATGGGAATGCGACCAGGGTTTAACCAAATGCCCCCA---CAAATGGGAGGAA 493 
r mgc2      405 ACCTAACCAAATGGGAATGCGACCAGGGTTTAACCAAATGCCCCCA---CAAATGGGAGGAA 463 
s6 mgc2     435 ACCTAACCAAATGGGAATGCGACCAGGGTTTAACCAAATGCCCCCA---CAAATGGGAGGAA 493 
a5969 mgc2  435 ACCTAACCAAATGGGAATGCGACCAGGGTTTAACCAAATGCCCCCA---CAAATGGGAGGAA 493 
ts 11 mgc2  435 ACCTAACCAAATGGGGATGCGACCAGGGTTTAACCAAATGCCCCCA---CAAATGGGAGGAA 493 
685 mgc2    372 ACTTAACCAAATGGGGATGCGACCAGGGTTTAACCAAATGCCCCCA---CAAATGGGAGGAA 430 
k730 mgc2   435 ACCTAACCACATGGGGATGCGACCAGGGTTTAACCAAATGCCACCTAACCAAATGGGTGGAA 496 
f mgc2      435 ACCTAACCACATGGGGATGCGGCCAGGGTTTAACCAAATGCCACCTAACCAAATGGGTGGAA 496 
k703 mgc2   435 ACCTAACCACATGGGGATGCGACCAGGGTTTAACCAAATGCCACCTAACCAAATGGGTGGAA 496 
k503 mgc2   435 ACCTAACCACATGGGGATGCGACAAGGGTTTAACCAAATGCCACCTAACCAAATGGGTGGAA 496 
 
  42hf51 mgc2   494 TGCCACCAAGACCAAACTTCCCTAACCAAATGCCTAATATGAACCAACCAAGACCAGGTTTC 555 
r mgc2      464 TGCCACCAAGACCAAACTTCCCTAACCAAATGCCTAATATGAACCAACCTAGACCAGGTTTC 525 
s6 mgc2     494 TGCCACCAAGACCAAACTTCCCTAACCAAATGCCTAATATGAATCAACCAAGACCAGGTTTC 555 
a5969 mgc2  494 TGCCACCAAGACCAAACTTCCCTAACCAAATGCCTAATATGAATCAACCAAGACCAGGTTTC 555 
ts 11 mgc2  494 TGCCACCAAGACCAAACTTCCCTAACCAAATGCCTAATATGAACCAACCAAGACCAGGTTTC 555 
685 mgc2    431 TGCCACCAAGACCAAACTTCCCTAACCAAATGCCTAATATGAACCAACCAAGACCAGGTTTC 492 
k730 mgc2   497 TGCCACCAAGACCAAACTTTCCTAACCAAATGCCAAATATGAATCAACCAAGACCAGGTTTC 558 
f mgc2      497 TGCCACCAAGACCAAACTTCCCTAACCAAATGCCTAATATGAATCAACCAAGACCAGGTTTC 558 
k703 mgc2   497 TGCCACCAAGACCAAACTTCCCTAACCAAATGCCTAATATGAATCAACCAAGACCAGGTTTC 558 
k503 mgc2   497 TGCCACCAAGACCAAACTTCCCTAACCAAATTTCTAATATGAATCAACCAAGACCAGGTTTC 558 
 
hf51 mgc2   556 AGACCACAACCTGGTGGTGGTGGGGTGCCGATGGGAAATAAAGCTGGAGGTGGGTTTAATCA 617 
r mgc2      526 AGACCACAACCTGGTGGTGG---GGTGCCGATGGGAAATAAAGCTGGAGGTGGGTTTAATCA 584 
s6 mgc2     556 AGACCACAACCTGGTGGTGG---GGTGCCGATGGGAAATAAAGCTGTAGGTGGGTTTAATCA 614 
a5969 mgc2  556 AGACCACAACCTGGTGGTGG---GGTGCCGATGGGAAATAAAGCTGTAGGTGGGTTTAATCA 614 
ts 11 mgc2  556 AGACCACAACCTGGTGGTGG---GGCGCCGATGGGAAATAAAGCTGGAGGTGGGTTTAATCA 614 
685 mgc2    493 AGACCACAACCTGGTGGTGG---GGCGCCGATGGGAAATAAAGCTGGAGGTGGGTTTAATCA 551 
k730 mgc2   559 AGACCACAACCTGGTGGTGG---GGTGCCGATGGGAAGTAAAGCTGGAGGCGGGTTTAATCA 617 
f mgc2      559 AGACCACAACCTGGTGGTGG---GGTCTCGATGGGAAATAAAGCTGGAGGCGGGTTTAATCA 617 
k703 mgc2   559 AGACCACAGCCTGGTGGTGG---GGCATCGATGGGAAATAAAGCTGGAGGCGGGTTTAATCA 617 
k503 mgc2   559 AGACCACAGCCTGGTGGTGG---GGCACCGATGGGAAATAAAGCTGGAGGTGGGTTTAATCA 617 
 
hf51 mgc2   618 C 618 
r mgc2      585 C 585 
s6 mgc2     615 C 615 
a5969 mgc2  615 C 615 
ts 11 mgc2  615 C 615 
685 mgc2    552 C 552 
k730 mgc2   618 C 618 
f mgc2      618 C 618 
k703 mgc2   618 C 618 
k503 mgc2   618 C 618 
  
 
Figure 3.2:  Alignment of the Mgc2  cytadhesion gene sequences in ten strains of 
M.gallisepticum. The arrows indicate the positions and directions of the LMMF/R set of 
primers. The alignments were carried out using the DNAssist® Version 2.2 program 
(www.dnassist.com).  
 
 
 
3.3.4.2 PCR amplification of the 16S rRNA, Mgc2 and M imitans genes. 
 
Each amplification reaction was made by addition of 5 µl of extracted DNA as 
template, 0.5 µl of each primer (100 µM), 1 µl of a set of dNTPs (100mM), 5 µl of 
10X concentration PCR buffer, 0.5 µl of Taq DNA polymerase (250 u/ml) and 
made up to a final volume of 50 µl with sterile distilled water. Distilled water was 
substituted for DNA in all negative controls. 
 
  Reactions were thermocycled on Mastercycler Personal (Eppendorf®). The 
initial denaturing step was carried out at 94 
0C for 5 min, followed by the 
denaturing step at 94 
0C for 30 s, annealing at 58 
0C (49 
0C for the repeated 
amplifications of the M. imitans genes) for 30 s and extension at 72 
0C for 90 s 
  43for a length of 30 cycles and the final extension step was carried out at 72 
0C for 
5 min.   
 
PCR products were stained with a loading dye and ran on a 1 % agarose gel at 
90 mV. Ethidium bromide was added to the gels for viewing under UV 
illumination.  
 
3.3.5 RFLP analyses 
 
Restriction maps for each of the ten strains in Figure 3.3 were determined using 
the NEBcutter V2  website  (tools.neb.com/NEBcutter2/index.php). These ten 
strains were used as reference strains because of their likeliness to be isolated 
from the field, following literature reviewed. A typing diagram was therefore 
constructed as part of this study and is shown in Figure 3.3 below. The letters A, 
B and C in the diagram indicate the three groups that these strains can be 
categorized under, subsequent to the choice of enzymes.  
 
 
PstI and BsmI  
 
        A  B 
         
 
 
 
    
    
HinFI
A5969, HF51, S6 
(192, 426) 
Ts-11 (434, 
63, 118) 
6/85 (192, 
242,118) 
EaeI and ClaI 
K730, K703, K503, F 
(500, 118) 
R (585) 
C  
 
 
 
 
 
K730 (618), K703 (585, 
35), K503 (391, 227), F 
(391, 63, 164) 
A5969 (615), HF51 (69, 
67, 479), S6 (615) 
A5969 
S6  
(615) 
  
Figure 3.3: RFLP typing of the 10 reference strains of M. gallisepticum. A, B and C 
indicate typing groups that can be constructed. Strains are underlined, restriction 
enzymes are in bold and the sizes resulting from actions of enzymes are bracketed. 
 
  443.3.5.1 The RFLP reaction of the Ts-11 vaccine strain 
 
Ts-11 was used as a positive control for reactions and was digested with BsmI. 
The reason for the utilization of Ts-11 as a positive control was to rapidly 
ascertain whether the flock was vaccinated with the Ts-11 strain or was naturally 
infected with wild-type strains.  Based on the restriction map constructed for Ts-
11,  PstI is unable to cut the Ts-11 strain and this is the reason that led to 
exclusion of this enzyme from the RFLP reaction of Ts-11. 
 
To perform the RFLP analysis, 1 µl of Buffer R and 0.5 µl of BsmI (10 u/µl per 
enzyme concentration) were added to 8.5 µl of the Mgc2-PCR product of Ts-11. 
The reaction was incubated at 37 
0C for 2 hours. The resulting product was 
stained with a loading dye and a 2 % low melt agarose gel containing ethidium 
bromide was run at 90 mV and viewed under UV illumination. 
 
3.3.5.2 The RFLP reactions of the field strains 
 
Field strains that were positive with the Mgc2-PCR were double-digested with 
BsmI and PstI and then compared to the groups in Figure 3.3. A 0.5 µl volume of 
each enzyme was added to 8 µl of the PCR product with 1 µl of Buffer R. The 
reaction was incubated at 37 
0C for 2 hours and the product was stained with a 
loading dye, ran on a 2 % low melt agarose gel with ethidium bromide at 90 mV 
and viewed under UV illumination. 
 
 
 
 
 
 
 
 
  453.4 Results 
 
3.4.1 Results of the PCR assays of the 16S rRNA genes. 
 
  1    2     3    4    5    6    7     8    9   10  11  12  13  14  15  16  17  18   19  20 
 
 
 
 
 
~579 bp 
 
 
 
Figure 3.4: Amplification of the 16S rRNA gene of isolates pooled from various farms in 
South Africa. Lane 1: 100 bp marker, Lanes 2-18 indicate various samples collected. 
Lanes 19 and 20 indicate the positive and negative controls, respectively. 
 
 
 
Zimbabwean samples 
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Figure 3.5: Amplifications of the 16S rRNA gene of the samples isolated from various 
farms in Zimbabwe. (A): Lane 1: 100 bp marker, lanes 2-16: samples tested, lanes 17 
and 18: positive and negative controls, respectively. (B): Lanes 1 and 17: 100 bp 
markers, lanes 2-14: samples tested, lanes 15 and 16: positive and negative controls, 
respectively. (C): Lane 1: 100 bp marker, lanes 2-16: samples tested, lanes 17 and 18: 
positive and negative controls, respectively.   
 
 
 
 
 
 
 
  473.4.2 Results of the PCR assays of the Mgc2 gene. 
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Figure 3.6: Amplification of the Mgc2 gene of samples isolated from South Africa. Lanes 
1 and 18: 100 bp marker, lanes 2-15 represent the samples tested. Lanes 16 and 17: 
positive and negative controls respectively. The two gel photographs represent one big 
gel. Detection was observed in lanes 2, 3, 4, 9 and 14; and these were designated 
Amplicons 1-5. 
 
Zimbabwean samples: 
 
  1    2     3    4     5     6    7     8    9   10  11  12   13  14   15  16   17   18 
 
A 
~615 bp 
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  1    2   3    4   5   6   7   8   9 10 11 12  13 14 15 16 17 18 
C 
~615 bp
Figure 3.7: Amplifications of the Mgc2 gene of samples isolated from Zimbabwe. (A): 
Lane 1: 100 bp marker, lanes 2-16: tested samples and lanes 17 and 18: positive and 
negative controls, respectively. (B): Lane 16: 100 bp marker, lanes 1-13: tested samples 
and lanes 14 and 15: positive and negative controls, respectively. (C): Lanes 1 and 18: 
100 bp markers, lanes 2-15: tested samples and lanes 16 and 17 represent the positive 
and negative controls, respectively.   
 
 
 
 
 
 
 
 
 
  493.4.3 Results of the PCR assays for the amplification of the gene encoding the M. 
imitans hypothetical protein.  
 
 
 
 
 1    2    3   4   5   6   7   8   9 10  11 12 13 14 15 16 17 18  19 
bp
Figure 3.8: Amplfications of the gene encoding the hypothetical protein of M. imitans. 
Lane 1 represents the 100 bp marker while lane 19 indicates the negative control. Lanes 
2 to 18 have been loaded with samples from South Africa. 
 
 
 
 
         1    2   3   4    5    6   7    8   9  10  11 12  13  14 15 16  
bp
Figure 3.9: Amplifications of the gene encoding the M. imitans hypothetical protein from 
the Zimbabwean samples. Lane 1: 100 bp marker, lanes 2-15: samples tested and lane 
16 is the negative control.    
 
 
 
 
  503.4.4 Results of the restriction digests performed on the Mgc2 amplicons. 
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Figure 3.10: (A) Lane 2: RFLP profile of the positive control, the Ts-11 vaccine strain 
after digestion of the Mgc2 gene with BsmI. Lane 1 represents a 50 bp marker while 
Figure B illustrates the band sizes of the utilized marker. 
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Figure 3.11: RFLP analyses of the Mgc2 amplicons. The digestion was performed with 
PstI and BsmI. Lane 1 indicates a 50 bp DNA marker while lanes 2-6 indicate the 
amplicons obtained in Figure 3.6.  
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Figure 3.12: RFLP analyses of the Mgc2 amplicons. Lane 1 indicates a 50 bp DNA 
marker. Lanes 2-6 indicate amplicons after double-digestion with CfrI and ClaI, while 
lanes 7-11 indicate digestion with HinFI. These amplicons were obtained in Figure 3.6. 
 bp         1    2     3     4      5     6     7     8      9   10   11 
~600 bp 
 
 
Table 3.2: RFLP results. Obtained approximate fragment sizes (bp) of the five Mgc2 
amplicons after digestion with various enzymes. 
Enzyme/Amplicon  PstI & BsmI  CfrI and ClaI  HinFI 
TS-11  63, 118, 434  ND  ND 
Sample 1  130,200 600  60,540 
Sample 2  130,200,260 590  60,530 
Sample 3  130,200 600  60,540 
Sample 4  600 610  610 
Sample 5  600 610  610 
. 
 
3.5 Discussions of results 
 
The first aim of this Chapter was to establish and optimize a PCR assay that can 
adequately detect M. gallisepticum isolates at both the level of the 16S rRNA 
gene and that of the Mgc2 gene. The aim was achieved when the positive control 
was consistently detected and the bands seen on a gel was of the expected size. 
 
Figure 3.1 indicates the positions of the primers and also shows the many 
conserved regions on the 16S rRNA gene. This is indicative of the high possibility 
for the detection of the M. imitans isolates that may be present in the field. These 
primers detected almost all the isolates under test only leaving out a few. 
Therefore, at the high level of conservation, M. gallisepticum or M. imitans have 
  52been detected. In comparison to this, only six isolates (figure 3.6) could be 
detected at the level of the Mgc2 gene. This might mean that only these are M. 
gallisepticum while the rest of the samples are only closely related species. Due 
to positive serological tests obtained from the farms and institutes that provided 
samples, it is assumed that the other samples (16S positive but Mgc2 negative) 
are M. imitans as cross-reactivity has been reported between M. gallisepticum 
and M. imitans (Harasawa et al., 2004).       
 
It would be expected of any M. gallisepticum strain to be detected at the level of 
the Mgc2 gene due to the high Mgc2 homology among the strains (figure 3.2), 
also as reported by Boguslavsky et al. (2000) and Garcia et al. (2005). However, 
as reviewed in Chapter1, Hong and co-workers (2005a) found that the M. 
gallisepticum isolates differed according to the different areas they were found in. 
This might suggest that the samples that were not detected (figure 3.6 and figure 
3.7) with the pair of Mgc2 primers designed are M. gallisepticum with a different 
Mgc2 gene with relation to those isolated outside Africa.  
 
In addition to this, Mycoplasma have been reported to be more susceptible to 
mutations than other bacteria (Woese et al., 1985) while M. gallisepticum was 
found to have a defective DNA repair system by Ghosh et al. (1997). It is in the 
interest of M. gallisepticum to frequently change the surface antigens as this 
allows the organism to evade the host immune system and facilitate its survival 
when adhered to the host respiratory tract. The haemagglutinin, Mgc2, a protein 
encoded for by Mgc2, is among the cytadhesins that are reported to undergo 
changes (Nascimento et al., 2005b). This fully suggests the possibility of changes 
that the Mgc2 nucleotide might posses among M. gallisepticum isolates.    
 
Attempts were made to detect the gene that encodes the hypothetical protein of 
M. imitans (figure 3.8 and 3.9). This would prove the other possibility of the 
isolates being M. imitans. The attempts were unsuccessful due to the lack of a 
positive control that would be utilized to set-up a sensitive PCR assay for the 
  53detection of the gene. Due to the constraints of time the control could not be 
awaited any further. However, there are very faint bands visible in some of the 
lanes in figure 3.9, that are absent in the negative control. This perhaps suggests 
the possibility of detection under optimized conditions. 
 
Recently, three novel Mycoplasma species were isolated from South Africa by 
Botes and co-workers (2005) from ostriches, proving great potential of different 
Mycoplasma to those already isolated in other countries and possibly continents. 
The results obtained in this section may also suggest a novel avian Mycoplasma 
that can neither be detected with the Mgc2 gene PCR as it is specific for M. 
gallisepticum, nor can it be detected with the hypothetical protein-encoding gene 
as it is specific for M. imitans.  
 
Besides being detected with the 16S rRNA gene primers, the samples were 
collected from flocks that were serologically positive for M. gallisepticum with 
corresponding clinical signs. Therefore, a highly related species might be present 
but may not necessarily be M. imitans. This was a similar case in a study done by 
Bradbury and co-workers (1993), which led to the first isolation of M. imitans. 
  
Figure 3.10 illustrated the RFLP pattern of Ts-11. The pattern was exactly the 
same as the theoretical digestion in Figure 3.3. Due to expected results being 
obtained, it shows that the reaction was well optimized and executed. The five 
amplicons obtained in Figure 3.6 were also digested as seen in Figure 3.11. It is 
observed from these profiles that the enzymes used are not a good typing 
system for samples 1 and 3 as the profiles obtained do not equal the total size of 
the amplicon obtained. The system is also not helping in profiling samples 4 and 
5 as no digestion is observed. Sample 2, however, was digested in such a way 
that the obtained bands do indeed add up to the total approximate sample size 
allowing some type of profiling of this sample. Though the profile of the sample 
does not fall in any of the groups of the reference strains in Figure 3.3 it is more 
similar to that of the 6/85 strain. 
  54Figure 3.12 shows digestion with CfrI and ClaI. It was observed that no digestion 
took place in the presence of theses enzymes. However, digestion was observed 
in a reaction with HinFI. The profiling from HinFI can give an indication that there 
is a certain nucleotide sequence that this enzyme recognizes in the Mgc2 as 
seen in samples 1 to 3 which have similar profiles. 
 
  The RFLP analyses thus provided an interesting addition to the detected M. 
gallisepticum isolates, in that they showed different profiles among the isolates 
themselves as well as being different from the Ts-11 strain. This is an indication 
of the diversity of the organism in South Africa and the assurance that wild-type 
M. gallisepticum is present in South Africa and not just vaccinated flocks are 
present (atleast with Ts-11).  
 
 
3.6 Conclusions 
 
A sensitive PCR was developed to detect M. gallisepticum at the level of the 
Mgc2 gene. This was achieved and RFLP analyses were performed. 
Observations made from the RFLP profiles indicate differences among the 
isolates. This proves the presence and diversity of M. gallisepticum in South 
Africa. Furthermore, the results show that the isolates are wild-type M. 
gallisepticum as they are different from those of the Ts-11 strain which is widely 
used for vaccination in South Africa. 
 
The 16S rRNA gene PCR was able to detect samples that were not detected with 
the  M. gallisepticum-specific PCR, suggesting the presence of different M. 
gallisepticum isolates, M. imitans isolates or novel but closely related 
Mycoplasma species, as supported by literature. 
 
 
 
  553.7 Future research 
It will be vital to optimize the detection of the other isolates not just at the level of 
the 16S rRNA gene, but also at the level of a specific gene that will characterize 
the isolates. Such a system will ascertain whether the organisms are indeed 
novel or just different. A positive control should be obtained for the correct 
optimization of the PCR amplification of the genes encoding the M. imitans 
hypothetical protein. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  56CHAPTER 4 
 
Identification of the PCR-detected samples and the DGGE profiling of the 
16S rRNA gene amplicons.  
 
4.1 Introduction 
 
Molecular techniques are believed to be accurate in identification of organisms as 
these techniques target genetic characteristics. Though phenotypic 
characteristics such as morphology still play a vital role in identification, most 
investigators are switching to molecular techniques as the basis of identification. 
Some of the most widely utilized molecular techniques were mentioned in 
Chapter 1 of this dissertation. 
 
Denaturing Gradient Gel Electrophoresis (DGGE) is one of the most important 
molecular techniques used not only in identification, but also in differentiation of 
closely related species. The technique is PCR-based and utilizes DNA melting 
properties to separate fragments differing by as little as 1 bp substitution and 
mismatch. The principle is that a duplex DNA migrates in a polyacrylamide gel 
until it reaches stable domain to unwind (Brossette and Wartell, 1994).  
 
Sometimes when the PCR assays of environmental DNA are investigated, the 
product can be a mixture of differing, but almost similar DNA sequences that 
represent many of the microbial organisms present in the environment. In such a 
case, the products will be of similar size (bp), making conventional separation by 
agarose gel electrophoresis result only in a single band that is largely non-
descriptive. DGGE can overcome this limitation by separating PCR products 
based on sequence differences that result in differential denaturing 
characteristics of the DNA.    
 
  57McAuliffe and co-workers (2005) stated that this method is based on the 
prevention of migration of DNA fragments following strand separation caused by 
chemical denaturants. It is further reported that though the technique has been 
extensively used for diversity analyses in microbial diversity, it has not been 
widely used for the identification and differentiation of pathogenic bacterial 
diversity. Using DGGE, these authors were able to differentiate 67 Mycoplasma 
species of human and veterinary origin and this showed improvement on current 
tests as diagnosis of Mycoplasma infection could be made directly from clinical 
samples in a period less than 24 hours.  
 
A total of 37 Mycoplasma species of veterinary significance, including M. 
gallisepticum, were differentiated by McAuliffe and co-workers (2003). The 
results show that DGGE could differentiate between 85 % of the organisms. M. 
gallisepticum could simply be differentiated from the other avian Mycoplasma 
used as it gave a unique band. The very closely related organism, M. imitans, 
was however not used in the study. The utilization of the organism would have 
provided a valuable input as it would point out whether both M. gallisepticum and 
M. imitans could be differentiated.   
 
4.2 Objectives 
 
This Chapter is aimed at identifying the detected isolates in Chapter 3 to strain 
level. Further investigations will ascertain if the results obtained correlate to the 
serological observations. Alignments will also be performed to find differences in 
the sequences of the detected isolates. Samples will be further evaluated for 
analyses of the number of organisms that have similar gene sequences to M. 
gallisepticum and M. imitans. Lastly, phylogenetic trees will be drawn to show 
distances between the isolates. 
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4.3.1 Sequencing of the Amplicons 
 
Sequencing reactions were carried out at Inqaba Biotech, South Africa. 
 
4.3.2 DGGE analyses 
 
Primers used 
 
For quantification of the bacterial diversity in the samples the universal bacterial 
primer pair 341F-GC: 5’-CGC CCG CCG CGC GCG GCG GGC GGG CCT ACG 
GGA GGC AGC AG-3’ and 517R: 5’-ATT ACC GCG GCT GCT GG-3’ was used. 
The expected size of the product was ~200 bp. The gel percentage prepared was 
thus 8 % (Table 4.1) 
 
Amplicons from the 16S rRNA gene PCR (Chapter 3) obtained with the primer 
pair LMGF/LMGR were used. 
 
Table 4.1: Percentage of acrylamide/bisacrylamide needed for a particular amplicon size 
range. 
 
Gel percentage                                                                       Base pair separation 
 6  %         300-1000  bp 
 8  %         200-400  bp 
           10 %                100-300 bp 
     
  
 
 
 
 
 
 
  59PCR assays 
 
The PCR parameters of the primer pair 341F-GC/517R PCR were as follows: the 
initial denaturing step was carried out at 95 
0C for 5 min, followed by the 
denaturing step at 95 
0C for 45 s, annealing step at 55 
0C for 45 sec and 
extension at 72 
0C for 25 cycles while the final extension step was carried out at 
72 
0C for 10 min. 
 
The DGGE preparations 
 
All reagents were obtained from BioRad:  Acrylamide/bisacrylamidesolution, 
Deionized formamide, Urea, Ammonium persulfate (APS), N,N,N’,N’-
tetramethylethylenediamine (TEMED), TAE buffer, Glacial Acetic Acid, Tris. 
 
 
Preparation of stock solutions: 
 
•  50x TAE 
o  242 g Trs-HCl 
o  57.1 ml Glacial Acetic Acid 
o  18.6  g EDTA 
o  Fill with distilled water up to 1 L 
o  Filter and store at room temperature. 
 
•  40 % Acrylamide/Bis (37:35:1) 
o  38.93 g acrylamide 
o  1.07 g bis-acrylamide 
o  Dissolve in 100 ml distilled water 
o  Filter and store at 4 
0C in the dark. 
 
 
  60•  Deionized formamide 
o  100 ml formamide  
o  Add ~5 g of Mixed Red Resin 
o  Shake overnight protected from light 
o  Filter and keep at 4 
0C in the dark. 
 
•  10  % APS 
o  Dissolve 1 g APS in 10 ml distilled water 
o  Filter and dispense in aliquots 
o  Store at -20 
0C until needed. 
 
Preparations of working 0 and 80% urea-formamide (UF) solutions.  
 
•  0 % UF (50 ml) 
o  10 ml 40 % acrlyamide/bis 
o  1 ml 50x TAE 
o  39 ml distilled water. 
 
•  80 % UF (50 ml) 
o  10 ml 40 % acrylamide/bis 
o  1 ml 50x TAE 
o  16 ml formamide 
o  16.8 g urea 
o  Fill to 50 ml with distilled water.  
 
The solutions can be stored at 4 
0C until needed.  
 
 
 
 
 
  61Table 4.2: Gradient urea-formamide (UF) solutions 
% UF   0 % stock solution volume (ml)    80 % UF stock solution volume (ml) 
10  %    8.75       1.25 
20  %    7.5       2.5     
30  %    6.25       3.75 
4 0   %     5        5      
50  %    3.75       6.25 
60  %    2.5       7.5 
70  %    1.25       8.75 
 
Both low and high density solutions were prepared by mixing the appropriate 
volumes of each 0 and 80 % stock solutions in two 15 ml tubes. A stacking 0 % 
UF solution was prepared separately in another tube. It was insured that all 
gradient delivery system components were ready prior to casting. Appropriate 
volumes of APS (63 µl) and TEMED (7 µl) were added to the gradient solutions. 
 
The gel was cast with the wheel, following the manual instructions. The APS and 
TEMED were added to the stacking solution, mixed and carefully delivered 
between the glasses with a Pasteur pipette to avoid contact with the gradient 
solution. When the solution reached the top, a comb was placed and the system 
was left for at least an hour to allow polymerization. 
 
The tank was filled with 7 L of 1x TAE. Once the gel had polymerized, the comb 
was removed. The gel was transferred to the tank and the wells washed. The 
buffer was pre-heated to 60 
0C before the samples were loaded. The gel was run 
at 200 V for 3 h. The gel was carefully removed and stained with ethidium 
bromide solution for 15 min. After staining, the gel was washed with distilled 
water and viewed under UV illumination.  
 
The bands were excised from the gel with a sterile blade and transferred into a 
sterile tube. Elution of DNA was carried out with 50 µl of distilled water and 
incubation at 50 
0C overnight.  
 
 
  624.4 Results 
 
4.4.1 BLAST results of PCR-detected isolates 
The Mgc2 PCR amplicons 
Table 4.3: BLAST results of the strains with the highest homology to the Mgc2 amplicon* 
Accession Description  Max 
score
Total 
score
Query 
coverage
E 
value
Max 
ident
AY556279.1
Mycoplasma gallisepticum strain 
K5033FTK00 Mgc2 (mgc2) 
gene, partial cds 
929 1205 100%  0.0  100%
AY556278.1
Mycoplasma gallisepticum strain 
K5033ATK00 Mgc2 (mgc2) 
gene, partial cds 
929 1205 100%  0.0  100%
AY556276.1
Mycoplasma gallisepticum strain 
K5027BTK00 Mgc2 (mgc2) 
gene, partial cds 
929 1205 100%  0.0  100%
AY556275.1
Mycoplasma gallisepticum strain 
K5011TK00 Mgc2 (mgc2) gene, 
partial cds 
929 1205 100%  0.0  100%
AY556271.1
Mycoplasma gallisepticum strain 
K4705CK99 Mgc2 (mgc2) gene, 
partial cds 
929 1205 100%  0.0  100%
AY556255.1
Mycoplasma gallisepticum strain 
K4311TK96 Mgc2 (mgc2) gene, 
partial cds 
929 1205 100%  0.0  100%
AY556254.1
Mycoplasma gallisepticum strain 
K4280CK96 Mgc2 (mgc2) gene, 
partial cds 
929 1205 100%  0.0  100%
AY556253.1
Mycoplasma gallisepticum strain 
K4246TK96 Mgc2 (mgc2) gene, 
partial cds 
929 1205 100%  0.0  100%
AY556229.1
Mycoplasma gallisepticum strain 
S6 Mgc2 (mgc2) gene, partial 
cds 
929 1205 100%  0.0  100%
AY556227.1
Mycoplasma gallisepticum strain 
A5969 Mgc2 (mgc2) gene, 
partial cds 
929 1205 100%  0.0  100%
U34842.1
Mycoplasma gallisepticum 
MGC2 precursor (mgc2) gene 
and MGC1 precursor (mgc1) 
gene, complete cds 
929 1205 100%  0.0  100%
*The “amplicon” represents the PCR product obtained in Figure 3.6, lane 4 of the gel. 
This amplicon will be designated Amplicon 2 henceforth.    
  63Table 4.4: BLAST results of the strains with the highest homology to the Mgc2 amplicon* 
 
Accession Description  Max 
score
Total 
score
Query 
coverage
E 
value
Max 
ident
AY556287.1
Mycoplasma gallisepticum 
strain K5111ATKY01 Mgc2 
(mgc2) gene, partial cds 
841 841 99%  0.0  99% 
AY556263.1
Mycoplasma gallisepticum 
strain K4465TK97 Mgc2 
(mgc2) gene, partial cds 
841 841 99%  0.0  99% 
AY556262.1
Mycoplasma gallisepticum 
strain K4423BTK97 Mgc2 
(mgc2) gene, partial cds 
841 841 99%  0.0  99% 
AY556261.1
Mycoplasma gallisepticum 
strain K4421ATK97 Mgc2 
(mgc2) gene, partial cds 
841 841 99%  0.0  99% 
AY556252.1
Mycoplasma gallisepticum 
strain K4236TK96 Mgc2 
(mgc2) gene, partial cds 
841 841 99%  0.0  99% 
AY556244.1
Mycoplasma gallisepticum 
strain K4043TK95 Mgc2 
(mgc2) gene, partial cds 
841 841 99%  0.0  99% 
AY556243.1
Mycoplasma gallisepticum 
strain K4029TK95 Mgc2 
(mgc2) gene, partial cds 
841 841 99%  0.0  99% 
AY556241.1
Mycoplasma gallisepticum 
strain K3944TK95 Mgc2 
(mgc2) gene, partial cds 
841 841 99%  0.0  99% 
AY556231.1
Mycoplasma gallisepticum 
strain 685 Mgc2 (mgc2) gene, 
partial cds 
841 841 99%  0.0  99% 
*The “amplicon” represents the PCR product obtained in Figure 3.6, lane 3 of the gel. 
This amplicon will be designated Amplicon 1 henceforth.   
 
The 16S rRNA gene PCR amplicons results: 
 
Three of the detected samples gave expected results that indicated that they are 
either M. gallisepticum or M. imitans isolates as seen in Table 4.5, Table 4.6 and 
Table 4.7 below:  
 
 
  64Table 4.5: BLAST results of the strains with the highest homology to the 16S rRNA gene 
amplicon*. 
  
(*The “amplicon” represents the PCR product obtained in Figure 3.4, lane 10 of the gel. 
This amplicon will be designated Sample 1 henceforth.)   
 
 
Accession Description  Max 
score
Total 
score
Query 
coverage
E 
value
Max 
ident
L35043.3
Mycoplasma gallisepticum 
strain A5969 genomic large 
direct repeat and flanking 
sequences 
1046 1876 69%  0.0  99% 
AE015450.1 Mycoplasma gallisepticum 
strain R complete genome  1046 2092 69%  0.0  99% 
M22441.1 M.gallisepticum 16S small 
subunit ribosomal RNA  1046 1046 69%  0.0  99% 
L24103.1
Mycoplasma imitans 16S 
ribosomal RNA (16S rRNA) 
gene 
1046 1046 69%  0.0  99% 
L08897.1
Mycoplasma gallisepticum 
(strain A5969) 16S-, 23S-, 5S 
ribosomal RNA (rrsA, rrlA, rrfA) 
genes 
1035 1035 69%  0.0  98% 
AM075207.1
Mycoplasma gallisepticum 
partial 16S rRNA gene, isolate 
MG-V25-2 
1031 1031 68%  0.0  99% 
U09788.1
Mycoplasma testudinis ATCC 
43263 16S rRNA gene, partial 
sequence 
893 893 69%  0.0  94% 
U44765.1
Mycoplasma alvi 16S ribosomal 
RNA (rrn) gene, partial 
sequence 
880 880 69%  0.0  94% 
AY531655.1
Mycoplasma amphoriforme 
strain A39 16S ribosomal RNA 
gene, partial sequence 
876 876 69%  0.0  93% 
AY531656.1
Mycoplasma amphoriforme 
strain M5572 16S ribosomal 
RNA gene, partial sequence 
869 869 68%  0.0  93% 
 
 
  65Table 4.6: BLAST results of the strains with the highest homology to the16S rRNA 
amplicon*. 
 
 
*The “amplicon” represents the PCR product obtained in Figure 3.5A, lane 3 of the gel.  
Accession Description  Max 
score
Total 
score
Query 
coverage
E 
value
Max 
ident
L35043.3
Mycoplasma gallisepticum 
strain A5969 genomic large 
direct repeat and flanking 
sequences 
959 1717 92%  0.0  99% 
AE015450.1 Mycoplasma gallisepticum 
strain R complete genome  959 1919 92%  0.0  99% 
M22441.1 M.gallisepticum 16S small 
subunit ribosomal RNA  959 959 92%  0.0  99% 
L24103.1
Mycoplasma imitans 16S 
ribosomal RNA (16S rRNA) 
gene 
959 959 92%  0.0  99% 
AM075207.1
Mycoplasma gallisepticum 
partial 16S rRNA gene, isolate 
MG-V25-2 
953 953 91%  0.0  99% 
L08897.1
Mycoplasma gallisepticum 
(strain A5969) 16S-, 23S-, 5S 
ribosomal RNA (rrsA, rrlA, rrfA) 
genes 
948 948 92%  0.0  99% 
U09788.1
Mycoplasma testudinis ATCC 
43263 16S rRNA gene, partial 
sequence 
806 806 92%  0.0  94% 
U44765.1
Mycoplasma alvi 16S ribosomal 
RNA (rrn) gene, partial 
sequence 
793 793 92%  0.0  93% 
AY531655.1
Mycoplasma amphoriforme 
strain A39 16S ribosomal RNA 
gene, partial sequence 
789 789 92%  0.0  93% 
AY531656.1
Mycoplasma amphoriforme 
strain M5572 16S ribosomal 
RNA gene, partial sequence 
782 782 92%  0.0  93% 
M23940.1 M.pirum 16S ribosomal RNA 
small subunit  750 750 92%  0.0  92% 
This amplicon will be designated Sample 2 henceforth.   
 
 
 
 
  66Table 4.7: BLAST results of the strains with the highest homology to the 16S rRNA 
amplicon*. 
 
Accession Description  Max 
score
Total 
score
Query 
coverage
E 
value
Max 
ident
L35043.3
Mycoplasma gallisepticum 
strain A5969 genomic large 
direct repeat and flanking 
sequences 
1044 1882 95%  0.0  99% 
AE015450.1 Mycoplasma gallisepticum 
strain R complete genome  1044 2088 95%  0.0  99% 
M22441.1 M.gallisepticum 16S small 
subunit ribosomal RNA  1044 1044 95%  0.0  99% 
L24103.1
Mycoplasma imitans 16S 
ribosomal RNA (16S rRNA) 
gene 
1044 1044 95%  0.0  99% 
AM075207.1
Mycoplasma gallisepticum 
partial 16S rRNA gene, isolate 
MG-V25-2 
1033 1033 95%  0.0  99% 
L08897.1
Mycoplasma gallisepticum 
(strain A5969) 16S-, 23S-, 5S 
ribosomal RNA (rrsA, rrlA, rrfA) 
genes 
1033 1033 95%  0.0  99% 
U09788.1
Mycoplasma testudinis ATCC 
43263 16S rRNA gene, partial 
sequence 
891 891 95%  0.0  94% 
U44765.1
Mycoplasma alvi 16S ribosomal 
RNA (rrn) gene, partial 
sequence 
878 878 95%  0.0  94% 
AY531655.1
Mycoplasma amphoriforme 
strain A39 16S ribosomal RNA 
gene, partial sequence 
874 874 95%  0.0  94% 
AY531656.1
Mycoplasma amphoriforme 
strain M5572 16S ribosomal 
RNA gene, partial sequence 
865 865 95%  0.0  93% 
M23940.1 M.pirum 16S ribosomal RNA 
small subunit  835 835 95%  0.0  92% 
*The “amplicon” represents the PCR product obtained in Figure 3.5B, lane 5 of the gel.  
This amplicon will be designated Sample 3 henceforth. 
 
 
 
 
  67However, two samples consistently gave similar results that have the highest 
homology to unexpected results as can be seen in Table 4.8 and Table 4.9 
below: 
 
Table 4.8: BLAST results of the strains with the highest homology to the 16S rRNA 
amplicon*. 
 
Accession Description  Max 
score
Total 
score
Query 
coverage
E 
value
Max 
ident
EF012270.1
Psychrobacter phenylpyruvicus 
strain NCTC 10526 16S 
ribosomal RNA gene, partial 
sequence 
933 933 97%  0.0 98% 
DQ406835.1
Psychrobacter phenylpyruvicus 
isolate YNLB41C-74-270505 
16S ribosomal RNA gene, partial 
sequence 
933 933 97%  0.0 98% 
CP000713.1 Psychrobacter sp. PRwf-1, 
complete genome  928 4640 97%  0.0  98% 
AF005192.1
Moraxella phenylpyruvica 16S 
ribosomal RNA gene, partial 
sequence 
928 928 97%  0.0 98% 
DQ191162.1
Psychrobacter sp. X 159 16S 
ribosomal RNA gene, partial 
sequence 
917 917 97%  0.0 97% 
EF204254.1
Psychrobacter phenylpyruvicus 
isolate F162 16S ribosomal RNA 
gene, partial sequence 
900 900 94%  0.0 98% 
*The “amplicon” represents the PCR product obtained in Figure 3.5C, lane 8 of the gel.  
This amplicon will be designated Pheny 1 henceforth. 
 
 
 
 
 
 
 
 
 
  68Table 4.9: BLAST results of the strains with the highest homology to the 16S rRNA 
amplicon. 
 
Accession Description  Max 
score
Total 
score
Query 
coverage
E 
value
Max 
ident
DQ406835.1
Psychrobacter phenylpyruvicus 
isolate YNLB41C-74-270505 
16S ribosomal RNA gene, partial 
sequence 
1035 1035 99%  0.0  99% 
CP000713.1 Psychrobacter sp. PRwf-1, 
complete genome  1029 5148 99%  0.0  99% 
AF005192.1
Moraxella phenylpyruvica 16S 
ribosomal RNA gene, partial 
sequence 
1029 1029 99%  0.0  99% 
DQ191162.1
Psychrobacter sp. X 159 16S 
ribosomal RNA gene, partial 
sequence 
1018 1018 99%  0.0  98% 
AJ609273.1 Psychrobacter arenosus 16S 
rRNA gene, type strain R7T  996 996 99%  0.0 98% 
EF632922.1
Uncultured bacterium clone Par-
w-85 16S ribosomal RNA gene, 
partial sequence 
990 990 99%  0.0 98% 
AM403658.1
Psychrobacter sp. 206(116zx) 
16S rRNA gene, strain 
206(116zx) 
990 990 99%  0.0 98% 
DQ447390.1
Uncultured bacterium clone 
RBbac164 16S ribosomal RNA 
gene, partial sequence 
990 990 99%  0.0 98% 
AY771725.1
Psychrobacter alimentarius 
isolate S3-15 16S ribosomal 
RNA gene, partial sequence 
990 990 99%  0.0 98% 
AY771724.1
Psychrobacter glacincola isolate 
S3-14 16S ribosomal RNA gene, 
partial sequence 
990 990 99%  0.0 98% 
AY573042.1
Psychrobacter sp. ARCTIC-P6 
16S ribosomal RNA gene, partial 
sequence 
990 990 99%  0.0 98% 
*The “amplicon” represents the PCR product obtained in Figure 3.5C, lane 12 of the gel.  
This amplicon will be designated Pheny 2 henceforth. 
 
 
 
 
  69The rest of the randomly selected samples could not be sequenced as they were 
found to have mixed templates. This is an indication of similar organisms that 
were present together in the field and were isolated as such from the host. This 
finding therefore led to choosing DGGE which could indicate the number of 
organisms with similar gene sequences that were present in those samples. 
These mixed amplicons were obtained from PCR assays of results shown in: 
Figure 3.4 (lanes 4, 8, 11, 17 and 18), Figure 3.5a (lanes 2, 4, 5, 6 and 11), 
Figure 3.5b (lanes 2, 3, 9 and 14) as well as Figure 3.5c (lanes 2, 3, 11 and 13).  
 
 
4.4.2 Results of the PCR amplifications with the universal primers: 
 
 
              1  2    3   4    5   6   7   8   9  10  11 12 13 14 15 16  
 
A 
~200 bp 
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           1    2   3    4   5   6   7   8    9 10 11 12 13  14 15 16  
B 
~200 bp 
 
Figure 4.1: PCR amplifications with the Universal primers. The first lanes on both A and 
B represent a 100 bp marker while the rest of the lanes represent randomly selected 
samples. The last lane of B is the negative control. 
 
 
4.4.3 Results of the DGGE analyses: 
 
The DGGE analysis of the universal primers amplicons: 
 
         1  2   3   4   5   6   7  8   9  10 11 12 13 14 1516 17 18 19 20  
 
Figure 4.2: The DGGE analysis of the universal primers amplicons.  
 
  71The DGGE analysis of the amplicons obtained from the 16 rRNA gene PCR. 
 
 
 
        1    2    3   4   5    6    7   8    9  10  11  12 13 14 15  16  17 18  19  20 
Figure 4.3: The DGGE analysis of the amplicons from the 16S rRNA gene. The 
amplicons were used in the same form as they were obtained in chapter 3. 
 
 
The primers used in Chapter 3 were not GC-clamped. In the absence of a GC-
clamp, double-stranded DNA that represents one organism is denatured, 
resulting in two strands of the DNA. Each strand is then represented as a band 
on the DGGE gel. Thus a GC-clamp helps keep the two strands together during 
the DGGE reaction. 
 
Due to this, Figure 4.3 might over-represent the number of microorganisms that 
were detected. Following this, a 40bp GC-clamp of the sequence: 5’-CGC CCG 
CCG CGC GCG GCG GGC GGG GCG GGG GCA CGG GGG G-3’ was added 
to the 5’-end of the LMGF primer (Table 3.1). A PCR assay to ascertain whether 
the primers would be able to detect the samples under test was run and the 
results can be seen in Figure 4.4 below:   
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~579 bp 
Figure 4.4: Amplifications of the 16S rRNA gene with a GC-clamp attached to the 
forward primer. Lanes 1 and 22 are the 100 bp markers, lanes 2-19 are the isolates 
under test while lanes 20 and 21: positive and negative controls, respectively. 
 
 
Following the amplifications in Figure 4.4, a DGGE analysis of the amplicons was 
performed as can be seen in Figure 4.5 below: 
 
 
 
      1     2    3    4     5    6   7   8    9    10  11  12   13   14 15  16  17    18  19   
Figure 4.5: The DGGE analysis of the 16S rRNA gene. The amplicons were achieved 
with a forward primer that had a GC-clamp attached to it. Lane 1 represents the positive 
control (Ts-11 vaccine) while the other lanes represent the detected amplicons. 
 
 
 
 
  734.4.4 The alignments of the 16S rRNA gene of the sequenced M. gallisepticum 
isolates 
 
 
R               CTGTACCATTTGAATAAGTAACGACTAACTATGTGCCAGCAGTCGCGGTAATACATAGGT 540 
MI              CTGTACCATTTGAATAAGTAACGACTAACTATGTGCCAGCAGTCGCGGTAATACATAGGT 513 
Sample1         ------------------------------------------------------------ 
Sample2         -------------------------------TTGCCAGGCCAGTGCGGTAATACATAGGT 29 
Sample3         -------------------------------TTTCCCACCCCGTGCGGTAATACATAGGG 29 
                                                                             
 
R               TGCAAGCGTTATCCGGATTTATTGGGCGTAAAACAAGCGCAGGCG-GATTAGAAAGTCTG 599 
MI              TGCAAGCGTTATCCGGATTTATTGGGCGTAAAACAAGCGCAGGCG-GATTAGAAAGTCTG 572 
Sample1         ---------------------TTGGGCGTAAAACAAGCGCAGGCGTGATTAGAAAGTCTG 39 
Sample2         TGCAAGCGTTATCCGGATTTATTGGGCGTAAAACAAGCGCAGGCG-GATTAGAAAGTCTG 88 
Sample3         TGCAAGCGTTAATCGGAATTACTGGGCGTAAAGCGCACGCAGGCGTGTTTGTTAAGTCAG 89 
                                      ********** *   ******** * **   ***** * 
 
R               GTGTTAAAAGCAATTGCTTAACGATTGTA-TGCATTGGAAACTTCTAGTCTAGAGTTTGG 658 
MI              GTGTTAAAAGCAATTGCTTAACGATTGTA-TGCATTGGAAACTTCTAGTCTAGAGTTTGG 631 
Sample1         GTGTTAAAAGCAATTGCTTAACGATTGTA-TGCATTGGAAACTTCTAGTCTAGAGTTTGG 98 
Sample2         GTGTTAAAAGCAATCGCTTAACGATTGTA-TGCATTGGAAACTTCTAGTCTAGAGTTTGG 147 
Sample3         ATGTGAAATCCCCGGGCTCAACCTGGGAACTGCATCTGATACTGGCAAGCTTGAGTCTCG 149 
                 *** ***  *    *** ***    * * *****  ** ***   *  ** **** * * 
 
R               TAGAGAGTCCTGGAACTCCATGTGGAGCGGTGAAATGCGTAGATATATGGAAGAACACCA 718 
MI              TAGAGAGTCCTGGAACTCCATGTGGAGCGGTGAAATGCGTAGATATATGGAAGAACACCA 691 
Sample1         TAGAGAGTCCTGGAACTCCATGTGGAGCGGTGAAATGCGTAGATATATGGAAGAACACCA 158 
Sample2         TAGAGAGTCCTGGAACTCCATGTGGAGCGGTGAAATGCGTAGATATATGGAAGAACACCA 207 
Sample3         TAGAGGGGGGTAGAATTCCAGGTGTAGCGGTGAAATGCGTAGAGATCTGGAGGAATACCG 209 
                ***** *   * *** **** *** ****************** ** **** *** ***  
 
R               GAGGCGAAGGCGAGGACTTGGGCCAATACTGACGCTTAGGCTTGAAAGTGTGGGGAGCAA 778 
MI              GAGGCGAAGGCGAGGACTTGGGCCAATACTGACGCTTAGGCTTGAAAGTGTGGGGAGCAA 751 
Sample1         GAGGCGAAGGCGAGGACTTGGGCCAATACTGACGCTTAGGCTTGAAAGTGTGGGGAGCAA 218 
Sample2         GAGGCGAAGGCGAGGACTTGGGCCAATACTGACGCTTAGGCTTGAAAGTGTGGGGAGCAA 267 
Sample3         GTGGCGAAGGCGGCCCCCTGGACGAAGACTGACGCTCAGGTGCGAAAGCGTGGGGAGCAA 269 
                * **********    * *** * ** ********* ***   ***** *********** 
 
R               ATAGGATTAGATACCCTAGTAGTCCACACTGTAAACGATGGATGTTAAGTGTCGGAGCG- 837 
MI              ATAGGATTAGATACCCTAGTAGTCCACACTGTAAACGATGGATGTTAAGTGTCGGAGCG- 810 
Sample1         ATAGGATTAGATACCCTAGTAGTCCACACTGTAAACGATGGATGTTAAGTGTCGGAGCG- 277 
Sample2         ATAGGATTAGATACCCTAGTAGTCCACACTGTAAACGATGGATGTTAAGTGTCGGAGCG- 326 
Sample3         ACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGATGTCGACTTGGAGGTTGTGCCC 329 
                * *************** ********* * **********     *  * *   * **   
 
R               --AATACTTCGGTGCTGCAGTTAACACATTAAACATCCTGCCTGAGTAGTACATTCGCAA 895 
MI              --AATACTTCGGTGCTGCAGTTAACACATTAAACATCCTGCCTGAGTAGTACATTCGCAA 868 
Sample1         --AATACTTCGGTGCTGCAGTTAACACATTAAACATCCTGCCTGAGTAGTACATTCGCAA 335 
Sample2         --AATACTTCGGTGCTGCAGTTAACACATTAAACATCCTGCCTGAGTAGTACATTCGCAA 384 
Sample3         TTGAGGCGTGGCTTCCGGAGCTAACGCGTTAAGTCGACCGCCTGGGGAGTACGGCCGCAA 389 
                   *  * * * * * * ** **** * ****     * ***** * *****   ***** 
 
R               GAATGAAACTCAAACGGAATTGACGGGGACCCGCACAAGTGGTGGAGCATGTTGCTTAAT 955 
MI              GAATGAAACTCAAACGGAATTGACGGGGACCCGCACAAGTGGTGGAGCATGTTGCTTAAT 928 
Sample1         GAATGAAACTCAAACGGAATTGACGGGGACCCGCACAAGTGGTGGAGCATGTTGCTTAAT 395 
Sample2         GAATGAAACTCAAACGGAATTGACGGGGACCCGCACAAGTGGTGGAGCATGTTGCTTAAT 444 
Sample3         GGTTAAAACTCAAATG-AATTGACGGGGGCCCGCACAAGCGGTGGAGCATGTGGTTTAAT 448 
                *  * ********* * *********** ********** ************ * ***** 
 
 
R               TCGACGGTACACGAAAAACCTTACCTAGACTTGACATCTTGGGCGAAGCTATAGAAATAT 1015 
MI              TCGACGGTACACGAAAAACCTTACCTAGACTTGACATCTTGGGCGAAGCTATAGAAATAT 988 
Sample1         TCGACGGTACACGAAAAACCTTACCTAGACTTGACATCTTGGGCGAAGCTATAGAAATAT 455 
Sample2         TCGACGGTACACGAAAAACCTTACCTAGACTTGACATCTTGGGCGAAGCTATAGAAATAT 504 
Sample3         TCGATGCAACGCGAAGAACCTTACCTGGTCTTGACATCCACAG-AACCTTGTAGAGATAC 507 
                **** *  ** **** ********** * *********    *  *   * **** ***  
 
 
  74R               AGTGGAGGTC-----AACCCAATGACAGGTGGTGCATGGTTGTCGTCAGCTCGTGTCGTG 1070 
MI              AGTGGAGGTC-----AACCCAATGACAGGTGGTGCATGGTTGTCGTCAGCTCGTGTCGTG 1043 
Sample1         AGTGGAGGTC-----AACCCAATGACAGGTGGTGCATGGTTGTCGTCAGCTCGTGTCGTG 510 
Sample2         AGTGGAGGTC-----AACCCAATGACAGGTGGTGCATGGTTGTCGTCAGCTCGTGTCGTG 559 
Sample3         GAGGGTGCCTTCGGGAACTGTGAGACAGGTGCTGCATGGCTGTCGTCAGCTCGTGTTGTG 567 
                   ** *        ***     ******** ******* **************** *** 
 
R               AGATGTTGGGTTAAGTCCCGC--AACGAG----CGCAACCCTTATCGTTAGTTACTTTGT 1124 
MI              AGATGTTGGGTTAAGTCCCGC--AACGAG----CGCAACCCTTATCGTTAGTTACTTTGT 1097 
Sample1         AGATGTTGGGTAAGTTCCCCCCCAAAAGG----CTATATATTTTTTATCTTGGAGTTTGT 566 
Sample2         AGATGTTGGGTTAAGTCCCCGCAAACCAAAACCCACTGCCCCCCCCCTTTTCTCCCCCCT 619 
Sample3         AGATGTTGGGTAAGTCCCCCCCAAATT--------------------------------- 594 
                *********** *   ***    **                                    
 
R               CTAACGAGACTGCCAACGTAAGTTGGAGGAAGGTGGGGATGACGTCAAATCATCATGCCC 1184 
MI              CTAACGAGACTGCCAACGTAAGTTGGAGGAAGGTGGGGATGACGTCAAATCATCATGCCC 1157 
Sample1         TTTT-------------------------------------------------------- 570 
Sample2         CTTTTTTCCTTTCTTTTTTTTCTTTTTTCA------------------------------ 649 
Sample3         ------------------------------------------------------------ 
                                                                             
 
Figure 4.6: Alignments of the 16S rRNA gene nucleotides of the sequenced samples 
with the R-strain of M. gallisepticum and the M. imitans gene. 
 
 
 
4.4.5 Alignments of the Mycoplasma isolates with the Pscychrobacter isolates 
based on the sequenced region of the 16S rRNA gene. 
 
 
Further alignments were performed with the inclusion of isolates that were found 
to be Psychrobacter. This was done for the investigation of the relatedness of M. 
gallisepticum and M. imitans to Psychrobacter. The relatedness became 
imperative due to the ability of the primers that were designed to detect M. 
gallisepticum and M. imitans also being able to detect Psychrobacter. The 
Psychrobacter species, P. phenylperuvicus was also included as a reference in 
the alignments as both the isolates that were found to be Psychrobacter seemed 
to have the highest similarity to it. 
 
 
MG              TTGGGCGTAAAACAAGCGCAGGCG-GATTAGAAAGTCTGGTGTTAAAAGCAATTGCTTAA 59 
MI              TTGGGCGTAAAACAAGCGCAGGCG-GATTAGAAAGTCTGGTGTTAAAAGCAATTGCTTAA 59 
Sample2         TTGGGCGTAAAACAAGCGCAGGCG-GATTAGAAAGTCTGGTGTTAAAAGCAATCGCTTAA 59 
Sample1         TTGGGCGTAAAACAAGCGCAGGCGTGATTAGAAAGTCTGGTGTTAAAAGCAATTGCTTAA 60 
Psych1          CTGGGCGTAAAGCGAGCGTAGGTG-GCTTGATAAGTCAGATGTGAAATCCCCGGGCTTAA 59 
Psych2          -------------GAGCGTAGGTG-GCTTGATAAGTCAGATGTGAAATCCCCGGGCTTAA 46 
Phenyl          CTGGGCGTAAAGGGAGCGTAGGTG-GCTTGATAAGTCAGATGTGAAATCCCCGGGCTTAA 59 
Sample3         CTGGGCGTAAAGCGCACGCAGGCGTGTTTGTTAAGTCAGATGTGAAATCCCCGGGCTCAA 60 
                               ** *** * * **   ***** * *** ***  *    *** ** 
 
 
MG              CGATTGTAT-GCATTGGAAACTTCTAGTCTAGAGTTTGGTAGAGAGTCCTGGAACTCCAT 118 
MI              CGATTGTA-TGCATTGGAAACTTCTAGTCTAGAGTTTGGTAGAGAGTCCTGGAACTCCAT 118 
Sample2         CGATTGTA-TGCATTGGAAACTTCTAGTCTAGAGTTTGGTAGAGAGTCCTGGAACTCCAT 118 
  75Sample1         CGATTGTA-TGCATTGGAAACTTCTAGTCTAGAGTTTGGTAGAGAGTCCTGGAACTCCAT 119 
Psych1          CCTGGGAACTGCATCTGATACTGTCAGGCTAGAGTAGGTGAGAGGGAGGTAGAATTTCAG 119 
Psych2          CCTGGGAACTGCATCTGATACTGTCAGGCTAGAGTAGGTGAGAGGGAGGTAGAATTTCAG 106 
Phenyl          CCTGGGAACTGCATCTGATACTGTTGGGCTAGAGTAGGTGAGAGGGAGGTAGAATTCCAG 119 
Sample3         CCTGGGAACTGCATCTGATACTGGCAAGCTTGAGTCTCGTAGAGGGGGGTAGAATTCCAG 120 
                *    * *  ****  ** ***      ** ****     **** *   * *** * **  
 
MG              GTGGAGCGGTGAAATGCGTAGATATATGGAAGAACACCAGAGGCGAAGGCGAGGACTTGG 178 
MI              GTGGAGCGGTGAAATGCGTAGATATATGGAAGAACACCAGAGGCGAAGGCGAGGACTTGG 178 
Sample2         GTGGAGCGGTGAAATGCGTAGATATATGGAAGAACACCAGAGGCGAAGGCGAGGACTTGG 178 
Sample1         GTGGAGCGGTGAAATGCGTAGATATATGGAAGAACACCAGAGGCGAAGGCGAGGACTTGG 179 
Psych1          GTGTAGCGGTGAAATGCGTAGAGATCTGAAGGAATACCGATGGCGAAGGCAGCCTCCTGG 179 
Psych2          GTGTAGCGGTGAAATGCGTAGAGATCTGAAGGAATACCGATGGCGAAGGCAGCCTCCTGG 166 
Phenyl          GTGTAGCGGTGAAATGCGTAGAGATCTGGAGGAATACCGATGGCGAAGGCAGCCTTCTGG 179 
Sample3         GTGTAGCGGTGAAATGCGTAGAGATCTGGAGGAATACCGGTGGCGAAGGCGGCCCCCTGG 180 
                *** ****************** ** ** * *** ***   *********       *** 
 
MG              GCCAATACTGACGCTTAGGCTTGAAAGTGTGGGGAGCAAATAGGATTAGATACCCTAGTA 238 
MI              GCCAATACTGACGCTTAGGCTTGAAAGTGTGGGGAGCAAATAGGATTAGATACCCTAGTA 238 
Sample2         GCCAATACTGACGCTTAGGCTTGAAAGTGTGGGGAGCAAATAGGATTAGATACCCTAGTA 238 
Sample1         GCCAATACTGACGCTTAGGCTTGAAAGTGTGGGGAGCAAATAGGATTAGATACCCTAGTA 239 
Psych1          CATCATACTGACACTGAGGTTCGAAAGCGTGGGTAGCAAACAGGATTAGATACCCTGGTA 239 
Psych2          CATCATACTGACACTGAGGTTCGAAAGCGTGGGTAGCAAACAGGATTAGATACCCTGGTA 226 
Phenyl          CATAATACTGACACTGAGGTGCGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTA 239 
Sample3         ACGAAGACTGACGCTCAGGTGCGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTA 240 
                    * ****** ** ***   ***** ***** ****** *************** *** 
 
 
MG              GTCCACACTGTAAACGATGGATGTTAAGTGTCGGAGCG---AATACTTCGGTGCTGCAGT 295 
MI              GTCCACACTGTAAACGATGGATGTTAAGTGTCGGAGCG---AATACTTCGGTGCTGCAGT 295 
Sample2         GTCCACACTGTAAACGATGGATGTTAAGTGTCGGAGCG---AATACTTCGGTGCTGCAGT 295 
Sample1         GTCCACACTGTAAACGATGGATGTTAAGTGTCGGAGCG---AATACTTCGGTGCTGCAGT 296 
Psych1          GTCCACGCCGTAAACGATGTCTACTAGTCGTTGGGGAACTTGATTCCTTAGTGACGCAGC 299 
Psych2          GTCCACGCCGTAAACGATGTCTACTAGTCGTTGGGGAACTTGATTCCTTAGTGACGCAGC 286 
Phenyl          GTCCACGCCGTAAACGATGTCTACTAGTCGTTGGGTCCCTTGAGGACTTAGTGACGCAGC 299 
Sample3         GTCCACGCCGTAAACGATGTCGACTTGGAGGTTGTGCCCTTGAGGCGTGGCTTCCGGAGC 300 
                ****** * **********     *    *   *        *    *   *   * **  
 
MG              TAACACATTAAACATCCTGCCTGAGTAGTACATTCGCAAGAATGAAACTCAAACGGAATT 355 
MI              TAACACATTAAACATCCTGCCTGAGTAGTACATTCGCAAGAATGAAACTCAAACGGAATT 355 
Sample2         TAACACATTAAACATCCTGCCTGAGTAGTACATTCGCAAGAATGAAACTCAAACGGAATT 355 
Sample1         TAACACATTAAACATCCTGCCTGAGTAGTACATTCGCAAGAATGAAACTCAAACGGAATT 356 
Psych1          TAACGCAATAAGTAGACCGCCTGGGGAGTACGGCCGCAAGGTTAAAACTCAAATG-AATT 358 
Psych2          TAACGCAATAAGTAGACCGCCTGGGGAGTACGGCCGCAAGGTTAAAACTCAAATG-AATT 345 
Phenyl          TAACGCAATAAGTAGACCGCCTGGGGAGTACGGTCGCAAGGTTACCACTCAAATG-AATT 358 
Sample3         TAACGCGTTAAGTCGACCGCCTGGGGAGTACGGCCGCAAGGTTAAAACTCAAATG-AATT 359 
                **** *  ***     * ***** * *****   ******  *   ******* * **** 
 
MG              GACGGGGACCCGCACAAGTGGTGGAGCATGTTGCTTAATTCGACGGTACACGAAAAACCT 415 
MI              GACGGGGACCCGCACAAGTGGTGGAGCATGTTGCTTAATTCGACGGTACACGAAAAACCT 415 
Sample2         GACGGGGACCCGCACAAGTGGTGGAGCATGTTGCTTAATTCGACGGTACACGAAAAACCT 415 
Sample1         GACGGGGACCCGCACAAGTGGTGGAGCATGTTGCTTAATTCGACGGTACACGAAAAACCT 416 
Psych1          GACGGGGGCCCGCACAAGCGGTGGAGCATGTGGTTTAATTCGATGCAACGCGAAGAACCT 418 
Psych2          GACGGGGGCCCGCACAAGCGGTGGAGCATGTGGTTTAATTCGATGCAACGCGAAGAACCT 405 
Phenyl          GACGGGGGCCCGCACAAGCGGTGGAGCATGTGGTTTACTTCGATGCAACGCGAAGAACCT 418 
Sample3         GACGGGGGCCCGCACAAGCGGTGGAGCATGTGGTTTAATTCGATGCAACGCGAAGAACCT 419 
                ******* ********** ************ * *** ***** *  ** **** ***** 
 
MG              TACCTAGACTTGACATCTTGGGCGAAGCTATAGAAATATAGTGGAGGTC-----AACCCA 470 
MI              TACCTAGACTTGACATCTTGGGCGAAGCTATAGAAATATAGTGGAGGTC-----AACCCA 470 
Sample2         TACCTAGACTTGACATCTTGGGCGAAGCTATAGAAATATAGTGGAGGTC-----AACCCA 470 
Sample1         TACCTAGACTTGACATCTTGGGCGAAGCTATAGAAATATAGTGGAGGTC-----AACCCA 471 
Psych1          TACCTGGTCTTGACATATCTAG-AATCCTGCAGAGATGCGGGAGTGCCTTCGGGAATCTA 477 
Psych2          TACCTGGTCTTGACATATCTAG-AATCCTGCAGAGATGCGGGAGTGCCTTCGGGAATCTA 464 
Phenyl          TACCTGGTCTTGACATATCTAG-AATCCTGCAGAGATGGGGAAGTGCCTTCGGGAATTTG 477 
Sample3         TACCTGGTCTTGACATCCACAG-AACCTTGTAGAGATACGAGGGTGCCTTCGGGAACTGT 478 
                ***** * ********     *  *   *  *** **      * *        **     
 
MG              ATGACAGGTGGTGCATGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCC-G 529 
MI              ATGACAGGTGGTGCATGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCC-G 529 
Sample2         ATGACAGGTGGTGCATGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCCG 530 
  76Sample1         ATGACAGGTGGTGCATGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTAAGTTCCCCC 531 
Psych1          GAA--------------------------------------------------------- 480 
Psych2          GAA--------------------------------------------------------- 467 
Phenyl          AATACAGGTGCTGCATGGCTGTCGTCAGCTCGTGTCGTCAGATGTTGGGTTATGTCCCGC 537 
Sample3         GAGACAGGTGCTGCATGGCTGTCGTCAGCTCGTGTTGTGAGATGTTGGGTAAGTCCCCCC 538 
                                                                             
 
MG              CAACG- 534 
MI              CAACG- 534 
Sample2         CAAACC 536 
Sample1         CCAAAA 537 
Psych1          ------ 
Psych2          ------ 
Phenyl          AACGAG 543 
Sample3         CAAATT 544 
    
                    
Figure 4.7: Alignments of the Mycoplasma isolates with the Psychrobacter isolates. 
Samples 1-3 represent isolates that had the highest homology for both M. gallisepticum 
and  M. imitans while Psych 1 and Psych 2 represent isolates that had the highest 
homology for Psychrobacter. Phenyl in the Figure represents Psychrobacter 
phenylpyruvicus that has been used as a reference species.                                                
 
 
4.4.6 Alignments of the sequenced Mgc2 amplicons with the Mgc2 sequences of 
the ten reference strains. 
 
S6              TTTTACCCAGTAGTGGGCGCAGGTGCTGGGTTGATTGTTGTTTCTTTACTCTTGGGTTTA 60 
Amplicon2       ------------------------------------------------------------ 
A5969           TTTTACCCAGTAGTGGGCGCAGGTGCTGGGTTGATTGTTGTTTCTTTACTCTTGGGTTTA 60 
HF51            TTTTATCCAGTAGTGGGTGCAGGTGCTGGGTTGATTGTTGTTTCTTTACTCTTGGGTTTA 60 
R               TTTTATCCAGTAGTGGGTGCAGGTGCTGGGTTGATTGTTGTTTCTTTACTCTTGGGTTTA 60 
TS11            TTTTATCCAGTAGTGGGTGCAGGTGCTGGGTTGATTGTTGTTTCTTTACTCTTGGGTTTA 60 
6/85            TTTTATCCAGTAGTGGGTGCAGGTGCTGGGTTGATTGTTGTTTCTTTACTCTTGGGTTTA 60 
Amplicon1       ------------------------------------------------------------ 
K730            TTTTACCCAGTAGTGGGTGCAGGTGCTGGGTTGATTGTTGTTTCTTTACTCTTGGGTTTA 60 
F               TTTTACCCAGTAGTGGGTGCAGGTGCTGGGTTGATCGTTGTTTCTTTACTCTTGGGTTTA 60 
K703            TTTTACCCAGTAGTGGGTGCAGGTGCTGGGTTGATTGTTGTTTCTTTACTCTTGGGTTTA 60 
K503            TTTTACCCAGTAGTGGGTGCAGGTGCTGGGTTGATTGTTGTTTCTTTACTCTTGGGTTTA 60 
                                                                             
 
S6              GGGATTGGGATTCCGATCGCTAAGAAAAAAGAAAGAATGATGATCCAAGAACGTGAAGAA 120 
Amplicon2       -----------TCCGATCGCTAAGAAAAAAGAAAGAATGATGATCCAAGAACGTGAAGAA 49 
A5969           GGGATTGGGATTCCGATCGCTAAGAAAAAAGAAAGAATGATGATCCAAGAACGTGAAGAA 120 
HF51            GGGATTGGGATTCCGATCGCTAAGAAAAAAGAAAGAATGATGATCCAAGAACGTGAAGAA 120 
R               GGGATTGGGATTCCGATCGCTAAGAAAAAAGAAAGAATGATGATCCAAGAACGTGAAGAA 120 
TS11            GGGATTGGGATTCCGATCGCTAAGAAAAAAGAAAGAATGATGATCCAAGAACGTGAAGAA 120 
6/85            GGGATTGGGATTCCGATCGCTAAGAAAAAAGAAAGAATGATGATCCAAGAACGTGAAGAA 120 
Amplicon1       ---------------------AARAAAAAAGAAAGAATGATGATCCAAGAACGTGAAGAA 39 
K730            GGGATTGGGATTCCGATCGCTAAGAAAAAAGAAAGAATGATGATCCAAGAACGTGAAGAA 120 
F               GGGATTGGGATTCCGATCGCTAAGAAAAAAGAAAGAATGATGATCCAAGAACGTGAAGAA 120 
K703            GGGATTGGGATTCCGATCGCTAAGAAAAAAGAAAGAATGATGATCCAAGAACGTGAAGAA 120 
K503            GGGATTGGGATTCCGATCGCTAAGAAAAAAGAAAGAATGATGATCCAAGAACGTGAAGAA 120 
                                     ** ************************************ 
 
 
S6              CACCAAAAGATGGTTGAATCCCTTGGTATAATCGAAGAACAAAATAAAACAGAAGCGATT 180 
Amplicon2       CACCAAAAGATGGTTGAATCCCTTGGTATAATCGAAGAACAAAATAAAACAGAAGCGATT 109 
A5969           CACCAAAAGATGGTTGAATCCCTTGGTATAATCGAAGAACAAAATAAAACAGAAGCGATT 180 
HF51            CACCAAAAGATGGTTGAATCCCTTGGAATAATTGAAGAACAAAATAAAACAGAAGCGATT 180 
R               CACCAAAAGATGGTTGAATCCCTTGGAATAATTGAAGAACAAAATAAAACAGAAGCGATT 180 
TS11            CACCAAAAGATGGTTGAATCCCTTGGAATAATCGAAGAACAAAATAAAACAGAAGCGATT 180 
6/85            CACCAAAAGATGGTTGAATCCCTTGGAATAATCGAACAACAAAATAAAACAGAAGCGATT 180 
Amplicon1       CACCAAAAGATGGTTGAATCCCTTGGAATAATCGAACAACAAAATAAAACAGAAGCGATT 99 
  77K730            CACCAAAAGATGGTTGAATCCCTTGGAATAATCGAGCAACAAAATAAAACAGAAGCGATT 180 
F               CACCAAAAGATGGTTGAATCCCTTGGAATAATCGAGCAACAAAATAAAACAGAAGCGATT 180 
K703            CACCAAAAGATGGTTGAATCCCTTGGAATAATCGAGCAACAAAATAAATCAGAAGCGATT 180 
K503            CACCAAAAGATGGTTGAATCCCTTGGAATAATTGAACAACAAAATAAAACAGAAGCGATT 180 
                ************************** ***** **  *********** *********** 
 
S6              GAGCCAACTGCAGCAGTGCCAACTGAAGAAGTTAATACTCAAGAACCAACTCAACCAGCT 240 
Amplicon2       GAGCCAACTGCAGCAGTGCCAACTGAAGAAGTTAATACTCAAGAACCAACTCAACCAGCT 169 
A5969           GAGCCAACTGCAGCAGTGCCAACTGAAGAAGTTAATACTCAAGAACCAACTCAACCAGCT 240 
HF51            GAGCCAACTGCAGCAGTGCCAACTGAAGAAGTTAATACTCAAGAACCAACTCAACCAGCT 240 
R               GAGCCAACTG---------------AAGAAGTTAATACTCAAGAACCAACTCAACCAGCT 225 
TS11            GAGCCAACTACATCAGTGCCAACTGAAGAAGTTAATACTCAAGAACCAACTCAACCAGCT 240 
6/85            GAATCAACTGCAGCAGTGCCAACTGAAGAAGTTAATACTCAAGAACCAACTCAACCAGCT 240 
Amplicon1       GAATCAACTGCAGCAGTGCCAACTGAAGAAGTTAATACTCAAGAACCAACTCAACCAGCT 159 
K730            GAGTCAACCACAGCAGTACCAACTGAAGAAGTTAATGTTCAAGAACCAACTCAACCAGCT 240 
F               GAGTCAACCACAGCAGTACCAACTGAAGAAGTTAATGTTCAAGAACCAACTCAACCAGCT 240 
K703            GAGTCAACCACAGCAGTACCAACTGAAGAAGTTAATGTTCAAGAACCAACTCAACCAGCT 240 
K503            GAGTCAACCACAGCAGTACCAACTGAAGAAGTTAATGTTCAAGAACCAACTCAACCAGCT 240 
                **  ****                 ***********  ********************** 
 
S6              GGTGTTAATGTAGCTAATAACCCTCAGATGGGGATCAATCAACCAGGATTTAATCAACCT 300 
Amplicon2       GGTGTTAATGTAGCTAATAACCCTCAGATGGGGATCAATCAACCAGGATTTAATCAACCT 229 
A5969           GGTGTTAATGTAGCTAATAACCCTCAGATGGGGATCAATCAACCAGGATTTAATCAACCT 300 
HF51            GGTGTTAATGTAGCTAATAACCCTCAGATAGGGATCAATCAACCAGGATTTAATCAACCT 300 
R               GGTGTTAATGTAGCTAATAACCCTCAGATGGGGATCAATCAACC---------------T 270 
TS11            GGTGTTAATGTAGATAATAACCCTCAGATGGGGATCAATCAGCCAGGATTTAATCAACCT 300 
6/85            GGTGTTAATGTAGATAATAATCCTCAGATGGGGATCAATCAGCCAGGATTTAATCAACCT 300 
Amplicon1       GGTGTTAATGTAGATAATAATCCTCAGATGGGGATCAATCAGCCAGGATTTAATCAACCT 219 
K730            GATGTAAATGTAGCTAATAATCCTCAGATGAGGATCAATCAACCAGGATTTAATCAACCT 300 
F               GATGTAAATGTAGTTAATAATCCTCAGATGGGGATCAATCAACCAGGATTTAATCAACCT 300 
K703            GATGTAAATGTAGCTAATAATCCTCAGATGGGGATCAATCAACCAGGATTTAATCAACCT 300 
K503            GATGTAAATGTAGCTAATAATCCTCAGATGGGGATCAATCAACCAGGATTTAATCAACCT 300 
                * *** ******* ****** ********  ********** **               * 
 
S6              CAGATTAATCCGCAATTTGGTCCTAATCCCCAACAAAGAATTAACCCACAGGGCTTTGGT 360 
Amplicon2       CAGATTAATCCGCAATTTGGTCCTAATCCCCAACAAAGAATTAACCCACAGGGCTTTGGT 289 
A5969           CAGATTAATCCGCAATTTGGTCCTAATCCCCAACAAAGAATTAACCCACAGGGCTTTGGT 360 
HF51            CAGATTAATCCGCAATTTGGTCCTAATCCCCAACAAAGAATTAACCCACAGGGCTTTGGT 360 
R               CAGATTAATCCGCAATTTGGTCCTAATCCCCAACAAAGAATTAACCCACAGTGCTTTGGT 330 
TS11            CAGATTAATCCGCAATTTATTCCTAATCCCCAACAAAGAATGAACCCACAGGGCTTTGGT 360 
6/85            CAGATTAATCCGCAATTTGGTCCTCATCCCCAACAAAGAATTAACCCGCAGGGCTTTGGT 360 
Amplicon1       CAGATTAATCCGCAATTTGGTCCTCATCCCCAACAAARAATTAACCCGCAGGGCTTTGGT 279 
K730            CAGATCAATCCACAATTTGGTCTTAATCCCCAACAAAGAATTAATCCACAGGGTTTTGGT 360 
F               CAGATCAATCCACAATTCGGTCTTAATCCCCAACAAAGAATTAATCCACAGGGTTTTGGT 360 
K703            CAGATCAATCCACAATTTGGTCTTAATCCCCAACAAAAAATTAATCCACAGGGTTTTGGT 360 
K503            CAGATCAATCCACAATTTGGTCTTAATCCCCAACAAAGAATTAATCCACAGGGTTTTGGT 360 
                ***** ***** *****   ** * ************ *** ** ** *** * ****** 
 
S6              GGCCCAATGCCACCTAACCAAATGGGAATGCGACCAGGGTTTAACCAAATGCCCCCACAA 420 
Amplicon2       GGCCCAATGCCACCTAACCAAATGGGAATGCGACCAGGGTTTAACCAAATGCCCCCACAA 349 
A5969           GGCCCAATGCCACCTAACCAAATGGGAATGCGACCAGGGTTTAACCAAATGCCCCCACAA 420 
HF51            GGCCCAATGCCACCTAACCAAATGGGAATGCGACCAGGGTTTAACCAAATGCCCCCACAA 420 
R               GGCCCAATGCAACCTAACCAAATGGGAATGCGACCAGGGTTTAACCAAATGCCCCCACAA 390 
TS11            GGCCCAATGCCACTTAACCAAATGGGGATGCGACCAGGGTTTAACCAAATGCCCCCACAA 420 
6/85            GGCCCAATGT-------------------------------------------------- 370 
Amplicon1       GGCCCAATGT-------------------------------------------------- 289 
K730            GGCCTAATTCCACCTAACCACATGGGGATGCGACCAGGGTTTAACCAAATGCCGCCACAG 420 
F               GGCCCAATGCCACCTAACCACATGGGGATGCGGCCAGGGTTTAACCAAATGCCGCCACAA 420 
K703            GGCCCAATGCCACCTAACCACATGGGGATGCGACCAGGGTTCAACCAAATGCCGCCACAG 420 
K503            GGCCCAATGCCACCTAACCACATGGGGATGCGGCCAGGGTTTAACCAAATGCCGACACAG 420 
                **** ***                                                     
 
 
S6              ATGGGAGGAATGCCACCTAACCAAATGGGAATGCGACCAGGGTTTAACCAAATGCCCCCA 480 
Amplicon2       ATGGGAGGAATGCCACCTAACCAAATGGGAATGCGACCAGGGTTTAACCAAATGCCCCCA 409 
A5969           ATGGGAGGAATGCCACCTAACCAAATGGGAATGCGACCAGGGTTTAACCAAATGCCCCCA 480 
HF51            ATGGGAGGAATGCCACCTAACCAAATGGGAATGCGACCAGGGTTTAACCAAATGCCCCCA 480 
R               ATGGGAGGAATGCCACCTAACCAAATGGGAATGCGACCAGGGTTTAACCAAATGCCCCCA 450 
TS11            ATGGGAGGAATGCCACCTAACCAAATGGGGATGCGACCAGGGTTTAACCAAATGCCCCCA 480 
6/85            -------------CACTTAACCAAATGGGGATGCGACCAGGGTTTAACCAAATGCCCCCA 417 
Amplicon1       -------------CACTTAACCAAATGGGGATGCGACCAGGGTTTAACCAAATGCCCCCA 336 
  78K730            ATGGGTGGGATGCCACCTAACCACATGGGGATGCGACCAGGGTTTAACCAAATGCCACCT 480 
F               ATGGGTGGGATGCCACCTAACCACATGGGGATGCGGCCAGGGTTTAACCAAATGCCACCT 480 
K703            GTGGGTGGGATGCCACCTAACCACATGGGGATGCGACCAGGGTTTAACCAAATGCCACCT 480 
K503            ATGGGTGGGATGCCACCTAACCACATGGGGATGCGACAAGGGTTTAACCAAATGCCACCT 480 
                             *** ****** ***** ***** * ****************** **  
 
S6              ---CAAATGGGAGGAATGCCACCAAGACCAAACTTCCCTAACCAAATGCCTAATATGAAT 537 
Amplicon2       ---CAAATGGGAGGAATGCCACCAAGACCAAACTTCCCTAACCAAATGCCTAATATGAAT 466 
A5969           ---CAAATGGGAGGAATGCCACCAAGACCAAACTTCCCTAACCAAATGCCTAATATGAAT 537 
HF51            ---CAAATGGGAGGAATGCCACCAAGACCAAACTTCCCTAACCAAATGCCTAATATGAAC 537 
R               ---CAAATGGGAGGAATGCCACCAAGACCAAACTTCCCTAACCAAATGCCTAATATGAAC 507 
TS11            ---CAAATGGGAGGAATGCCACCAAGACCAAACTTCCCTAACCAAATGCCTAATATGAAC 537 
6/85            ---CAAATGGGAGGAATGCCACCAAGACCAAACTTCCCTAACCAAATGCCTAATATGAAC 474 
Amplicon1       ---CAAATGGGAGGAATGCCACCAAGACCAAACTTCCCTAACCAAATGCCTAATATGAAC 393 
K730            AACCAAATGGGTGGAATGCCACCAAGACCAAACTTTCCTAACCAAATGCCAAATATGAAT 540 
F               AACCAAATGGGTGGAATGCCACCAAGACCAAACTTCCCTAACCAAATGCCTAATATGAAT 540 
K703            AACCAAATGGGTGGAATGCCACCAAGACCAAACTTCCCTAACCAAATGCCTAATATGAAT 540 
K503            AACCAAATGGGTGGAATGCCACCAAGACCAAACTTCCCTAACCAAATTTCTAATATGAAT 540 
                   ******** *********************** ***********  * ********  
 
 
S6              CAACCAAGACCAGGTTTCAGACCACAACCTGGTGGTGGGGTGCCGATGGGAAATAAAGCT 597 
Amplicon2       CAACCAAGACCAGGTTTCAGACCACAACCTGGTGGTG----------------------- 503 
A5969           CAACCAAGACCAGGTTTCAGACCACAACCTGGTGGTGGGGTGCCGATGGGAAATAAAGCT 597 
HF51            CAACCAAGACCAGGTTTCAGACCACAACCTGGTGGTGGTGGGGTGCCGATGGGAAATAAA 597 
R               CAACCTAGACCAGGTTTCAGACCACAACCTGGTGGTGG---GGTGCCGATGGGAAATAAA 564 
TS11            CAACCAAGACCAGGTTTCAGACCACAACCTGGTGGTGG---GGCGCCGATGGGAAATAAA 594 
6/85            CAACCAAGACCAGGTTTCAGACCACAACCTGGTGGTGG---GGCGCCGATGGGAAATAAA 531 
Amplicon1       CAACCAAGACCAGGTTTCAGACCACAACCTGGTGGTGG---GGCGCCRATGGGAAATAAA 450 
K730            CAACCAAGACCAGGTTTCAGACCACAACCTGGTGGTGG---GGTGCCGATGGGAAGTAAA 597 
F               CAACCAAGACCAGGTTTCAGACCACAACCTGGTGGTGG---GGTCTCGATGGGAAATAAA 597 
K703            CAACCAAGACCAGGTTTCAGACCACAGCCTGGTGGTGG---GGCATCGATGGGAAATAAA 597 
K503            CAACCAAGACCAGGTTTCAGACCACAGCCTGGTGGTGG---GGCACCGATGGGAAATAAA 597 
                ***** ******************** **********                        
 
S6              GTAGGTGGGTTTAATCAC--- 615 
Amplicon2       --------------------- 
A5969           GTAGGTGGGTTTAATCAC--- 615 
HF51            GCTGGAGGTGGGTTTAATCAC 618 
R               GCTGGAGGTGGGTTTAATCAC 585 
TS11            GCTGGAGGTGGGTTTAATCAC 615 
6/85            GCTGGAGGTGGGTTTAATCAC 552 
Amplicon1       GCTGGAGGTG----------- 460 
K730            GCTGGAGGCGGGTTTAATCAC 618 
F               GCTGGAGGCGGGTTTAATCAC 618 
K703            GCTGGAGGCGGGTTTAATCAC 618 
K503            GCTGGAGGTGGGTTTAATCAC 618 
                                      
Figure 4.8: The Mgc2 gene alignments of the reference strains with the two sequenced 
amplicons. 
 
 
 
 
 
 
 
 
 
 
  794.4.7 Phylogenetic trees  
 
The 16S rRNA gene phylogenetic tree  
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Figure 4.9: A phylogenetic tree based on the partial 16S rRNA gene sequences of the 
reference strains of M. gallisepticum (MG) and M. imitans (MI), samples that had the 
highest homology to M. gallisepticum and M. imitans (Samples 1-3) as well as those 
found to be Psychrobacter (Psych 1& 2). Phenyl represents a Psychrobacter reference, 
P. phenylpyruvicus. Constructed using MEGA version 3 Software. 
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Figure 4.10: A phylogenetic tree based on the Mgc2 gene of the 10 reference strains 
and two products of the Mgc2-PCR designated Amplicon 1 & 2. Constructed using 
MEGA version 3 Software. 
  814.5 Discussions of results. 
 
The first aim of this Chapter was to identify the amplicons obtained from the PCR 
assays to strain level. The results obtained in achieving this aim are of vital 
importance. Three amplicons of the 16S rRNA gene PCR showed the highest 
homology to the same organisms. The organisms were found to be either M. 
gallisepticum or M. imitans, which were expected as products of this PCR. The 
two M. gallisepticum isolates that came up were the R and A5969 strains. This 
might indicate the possibility of the isolates obtained in this study as being either 
of these two strains. However, the possibility of the samples being either of those 
two strains only, was disproved by further investigations made in Genbank. 
 
These investigations were to quantify the information available on M. 
gallisepticum in Genbank. It was thus found that completed sequences of the 
16S rRNA gene in Genbank for M. gallisepticum are of the strains: R and A5969 
only, while the rest are partial sequences of limited information. For this reason, 
any other sequence obtained by an investigator on a certain isolate will be limited 
to these two strains only when a search is made in Genbank, regardless of 
whether the strain is R, A5969 or neither. A further limitation is that any novel 
species or strain that is similar to M. gallisepticum will be recognized as being 
either one of the two strains or M. imitans.  
 
As expected, M. imitans was present in the results as being one of the possible 
species to the amplicon obtained. However, it is not clear from Genbank which 
strain it is as it is only entered as a gene. It is however evident that the degree of 
relatedness decreases when the BLAST results start outlining other species of 
Mycoplasma. This is proof that the organisms are definitely of M. gallisepticum or 
M. imitans origin, or a novel species that is closely related to these two 
organisms than any other currently known Mycoplasma species.   
 
  82The Figures 4.4 and 4.5 show strange and unexpected results that indicate that 
the highest homology of the isolates is to the Genus Psychrobacter with P. 
phenylpyruvicus being the most likely species. The results were thought to be 
strange initially due to the name Psychrobacter possibly indicating an 
extremophilic genus. The members of the genus are however psychotolerant 
(Bozal et al., 2003) and grow at temperatures of approximately -10 
0C but can 
also grow at much higher temperatures of 40 
0C. Isolation of some of these 
organisms has been reported from poultry (Juni & Heym, 1986) while Bowman 
and co-workers reported isolation from the faecal matter of a variety of bird 
species. 
 
Following this information, the two isolates found to be Psychrobacter and the 
three found to be Mycoplasma were used to construct a Phylogenetic tree. 
References used were the M. gallisepticum strain R, the M. imitans isolate and 
the P. phenylpyruvicus sequences (Figure 4. 9). The results from the tree show 
that Sample 1, M. gallisepticum and M. imitans are very similar as they form one 
cluster. Joining this cluster is Sample 2 at a 100 % confidence value. This 
clustering supports what was found when a BLAST search was performed. The 
search indicated that Samples 1 to 3 are Mycoplasma.  
 
Interesting to note is that Sample 3, also found to be Mycoplasma, is very far 
from the other Mycoplasma species on the tree. This sample is rather closer to 
the  Psychrobacter isolates as it joins a Psychrobacter cluster at a 100 % 
confidence value. This suggests a Mycoplasma that has evolved away from the 
other Mycoplasma. It is important to note that this tree was drawn solely to show 
the relatedness of partial sequences of Samples 1-3 with those in Genbank and 
interest was only in these isolates. It is therefore very important to consider the 
differences that are apparent from the tree at this region, as it seems that Sample 
1 is the only very closely related species to M. gallisepticum and M. imitans. The 
alignments outline the variable and non-variable regions that were important for 
the construction of the tree drawn.  
  83The second tree (Figure 4.10) is based on the Mgc2 gene products and the ten 
reference strains used. Two of the five amplicons could be properly sequenced 
and the BLAST results are outlined in Table 4.3 and 4.4 for Amplicon 2 and 1, 
respectively. The results also show a tremendous distance in the two amplicons. 
Amplicon 2 has clustered on higher branches in the tree while Amplicon 1 has 
clustered on the second branch of the tree. Important to note is also the fact that 
Amplicon 2 has clustered with the two wildtype pathogenic strains while Amplicon 
1 has clustered with the vaccine strain 6/85. The sequence of the 6/85 strain is 
very particular as can be seen in Figure 4.8. There are many gaps present in the 
sequence of this strain and such gaps can only be seen in Amplicon 1 in the 
same alignment figure.  Furthermore, Figure 3.6 lane 3 indicates the first 
detection of this isolate and it can be seen from the gel picture that the size of the 
band is a bit smaller (by position) that the other bands and among all the ten 
reference strains, strain 6/85 has the smallest Mgc2 size. In addition to this the 
RFLP profile obtained for this strain (Figure 3.11 and Table 3.2) is somewhat 
similar to that of the 6/85 strain, strongly suggesting that this strain is 6/85 or a 
mutant thereof.   
 
The results of the tree are in correlation with those in Table 4.3 and 4.4. In Table 
4.3, for the identification of Amplicon 2, there are many strains from the K-series 
after which the only other strains are S6 and A5969 which can be clearly seen in 
the table as well. The K-series strains, S6 and A5969 were all isolated from the 
USA in various states and some of the K-series strains that came out of a search 
in Table 4.3 were involved in various outbreaks in the USA (Ferguson et al., 
2005). Using GTS (Gene-targeted Sequencing) and RAPD, Ferguson and co-
workers (2005) showed that the strain A6959 and S6 fall in the same group with 
reference to their Mgc2 properties. The tree in Figure 4.10 correlates well with 
this data. 
 
There is an evolutionary history behind the strains that came up in Table 4.4, that 
were listed as being similar to Amplicon 1. These strains were all isolated from 
  84the USA and were found to have either originated from 6/85-vaccinated flocks or 
were  found to be very similar to the vaccine strain 6/85 when they were isolated 
from the field. This serves as an even greater suggestion of Amplicon 1 being of 
6/85 origin. When Ferguson and co-workers (2005) investigated these strains 
they found that the Mgc2-profiling of these strains was also the same as that of 
the 6/85 strain. Other than the similar Mgc2-profiling between these strains, 
results on other targeted genes yielded the same results.   It is not clear if these 
strains are pathogenic, but due to their very high similarity to the vaccine strain 
they may also have similar properties.  
 
The DGGE assays were used to investigate whether the amplicons from the PCR 
products were indeed mixed. Figure 4.2, which is the DGGE analysis of the 
amplicons obtained by amplification with the universal primers, shows the vast 
number of organisms that are present in the samples and this might also give an 
idea of the under-representation of the desired test-organism. The gel 
photographs in Figure 4.1 which are the same amplicons obtained with the 
universal primers, showed these samples as single bands but from using DGGE 
it is apparent that there are many more bands. This proved the efficacy of this 
method and therefore DGGE was chosen as a method of choice to ascertain 
whether the samples that could not be sequenced were indeed mixed. There is 
great scope for diversity studies in this case.  
 
Figure 4.3 shows the DGGE analyses of the samples as they were obtained in 
Chapter 3. It is believed that the DNA of the amplicons was denatured and the 
bands hence represent single-stranded DNA. This is due to the exclusion of the 
GC-clamp from the assays. To make a more accurate quantification of the 
isolates detected with the 16S rRNA gene-PCR, a GC-clamp was included in the 
PCR assay and samples could still be detected with the same PCR parameters 
(Figure 4.4). The new amplicons were run on the DGGE gel and the number of 
bands was reduced (Figure 4.5).  This is due to fact that a GC-clamp prevents 
  85double-stranded DNA from separating and the single strands from presenting as 
many bands when a gel is viewed. 
 
Important to note in Figure 4.5 are the two bands in lane 1 which contains Ts-11, 
a commercial live vaccine. In theory this would mean that Ts-11 might be mixed, 
while on the other hand, the most probable reason is that Ts-11 has two copies 
of this gene in its genome. If proven further, this hypothesis will greatly improve 
information on this vaccine strain. Lane 2 in the same figure has the same profile 
as that of the Ts-11 strain while the rest of the lanes have different profiles to 
these two. This is an indication that while some flocks might be vaccinated with 
the Ts-11 vaccine, others are infected with wild-type Mycoplasma.  Due to time 
constraints, the bands in all the lanes could not be fully characterized, but the 
work completed has provided significant results.  
 
 
  4.6 Conclusions 
 
The diversity of M. gallisepticum in South Africa was further proven by 
sequencing results of the Mgc2 gene in addition to the RFLP analyses obtained. 
It has been shown in this study that isolates found in South Africa share certain 
characteristics with those isolated in the USA. However, lack of information on 
the South African isolates limits the exact identification of organisms under test. 
 
While some Mycoplasma isolates seem to be related to those that have been 
isolated outside South Africa, a phenomenon of a totally different Mycoplasma 
isolate was strongly suggested in this study based on the phylogenetic tree. 
 
To further prove the different Mycoplasma strains, biological properties in support 
of these findings will be required. Furthermore, to determine that the different 
Mycoplasma are indeed novel, serological tests need to be performed as they will 
provide more insight into the antigenic diversity of these Mycoplasma. This 
  86proves the limitations in molecular techniques if used without coupling with 
serological techniques as well as challenge studies, emphasizing the importance 
of serology.    
 
The vaccine strain Ts-11, used as a positive control in this study, might contain 
two copies of the amplified region of the 16S rRNA gene. This shows the 
limitation of the DGGE analyses as it might indicate such a case of two copies as 
different organisms. Alternatively, Ts-11 might indeed be mixed with an organism 
of the same sequence in this region. 
 
4.6 Future research 
 
For further characterization, organisms must be grown and challenge 
experiments performed. Bands from DGGE must also be characterized. 
However, it would be necessary for a number of reference strains of M. 
gallisepticum to be obtained for further optimization of the assay. Those 
reference strains can be used as markers to which the tested samples can be 
compared. Cloning of these amplicons is also advised.    
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SUMMARY  
 
Mycoplasma gallisepticum is the most pathogenic avian Mycoplasma species 
and leads to great economic losses worldwide (Kleven, 2003). Prevention and 
control of this organism has been achieved by vaccination and antibiotic 
administration. Ferraz and Danelli (2003) reported on the most widely used live 
vaccines which are MG-F, Ts-11 and 6/85. The MG-F strain is currently not 
registered for use in South Africa.   
 
M. imitans is the most closely related organism to M. gallisepticum and was 
tentatively identified as M. gallisepticum until Bradbury and co-workers (1993) 
defined it as a different species. However, this species is still misidentified as M. 
gallisepticum due to serological cross-reactivity and M. gallisepticum specific 
primers also detecting M. imitans (Markham et al., 1999).  
 
While  M. gallisepticum has been characterized in some countries, very little 
information is documented on the South African isolates. It therefore became the 
aim of this study to investigate the presence and diversity of this organism in 
Southern Africa, investigate the presence of M. imitans as well as to establish the 
relatedness of the Southern African strains to those isolated outside Africa.  
 
Samples were collected from serologically positive birds from different farms in 
South Africa and Zimbabwe. Two PCR (Polymerase Chain Reaction) assays 
were optimized, one to detect M. gallisepticum of a specific gene Mgc2, the other 
to detect both M. gallisepticum and M. imitans.  
 
A total of five samples were detected with the Mgc2-PCR, while almost all 
samples could be detected with the 16S rRNA gene-PCR. This is a possible 
indication of a different M. gallisepticum isolate that can be detected on the 16S 
  88rRNA gene level but not at the Mgc2 level, or the isolate could indeed be M. 
imitans. In a study by Woese and co-workers (1985), the Mgc2 gene was 
implicated as one of the rapidly mutating genes due to adaptation, a possible 
reason for the non- detection of Mgc2 but the detection of the 16S rRNA gene.  
 
Of the sequenced 16S rRNA gene-PCR amplicons, M. gallisepticum and M. 
imitans  had the highest homology. However, there are only two complete 
sequences of the 16S rRNA genes that belong to two M. gallisepticum strains 
deposited in Genbank, thus limiting the information on the isolates detected. 
Restriction Fragment Length Polymorphisms (RFLPs) were performed and well 
optimized. Ts-11 gave the expected profile while tested samples could not be 
placed in any of the reference groups. It was observed, however, that the RFLP 
profile of one of the amplicons was similar to the 6/85 vaccine strain and 
subsequent results correlated with this finding. Two of the amplicons could be 
sequenced and further analyzed. 
 
A phylogenetic tree showed one of the amplicons clustering away from the other 
Mycoplasma  species though its sequence was found to be that of M. 
gallisepticum or M. imitans. In another tree, one of the amplicons showed more 
homology to the pathogenic strains while the other showed more homology to the 
vaccine strain 6/85.  
 
The DGGE analyses showed that the amplicons consist of a mixed template 
which was the reason why some samples could not be properly sequenced. This 
might be an indication of mixed infection within the flocks. However, it was 
expected of the 16S rRNA to give these results.  Furthermore, the DGGE results 
indicated that the vaccine strain Ts-11 is used to vaccinate some of the flocks, 
while other flocks are infected with wild-type Mycoplasma.  The results also 
suggest the possibility of the presence of two copies of the amplified region of the 
16S rRNA gene in this vaccine strain.  
 
  89The study has confirmed the presence of M. gallisepticum and the possible 
presence of M. imitans. Different yet closely related Mycoplasma isolates are 
also present in South Africa. These could represent novel strains or species and 
warrant further investigation. 
 
OPSOMMING 
 
Mycoplasma gallisepticum is die mees patogeniese voël Mycoplasma spesie en 
ly tot groot ekonomiese verliese wêreldwyd (Kleven,  2003).  Voorkoming en 
beheer van hierdie organisme is bewerkstellig deur vaksinasie.  MG-F, Ts-11 en 
9/85 is volgens Ferraz en Danelli (2003) die mees gebruikte lewendige 
entstowwe. Die MG-F stam is tans nie geregistreer vir gebruik in Suid Afrika nie. 
 
M. imitans is die naaste verwant aan M. gallisepticum en was eksperimenteel 
geïdentifiseer as M. gallisepticum totdat Bradbury en medewerkers (1993) dit as 
ŉ verskillende spesie geïdentifiseer het.  Hierdie spesie word egter nog steeds 
verkeerdelik geïdentifiseer as M. gallisepticum as gevolg van serologiese 
kruisreaktiwiteit en omdat die M. gallisepticum spesifieke voorvoerders ook 
M. imitans identifiseer (Markham et al., 1999).   
M. gallisepticum is al geïdentifiseer in sommige lande, maar baie min inligting is 
beskikbaar oor die voorkoms van hierdie organisme in Suid-Afrika.  Dit het 
gevolglik die doel van hierdie studie geword om die teenwoordigheid en 
diversiteit van die organismes in Suider-Afrika te ondersoek, die teenwoordigheid 
van M. imitans in Suid-Afrika te ondersoek asook om die verwantskap van die 
Suider-Afrikaanse spesies met die wat buite Afrika geïsoleer is, te bepaal.  
Monsters is versamel van serologies positiewe voëls vanaf verskillende plase in 
Suid-Afrika en Zimbabwe.  Twee PKR reaksies was gestandaardiseer, een om 
die  M. gallisepticum deur middel van amplifikasie van die Mgc2 geen te 
  90identifiseer en ŉ tweede PKR reaksie om M. gallisepticum en M. initans te 
identifiseer.  
ŉ Totaal van vyf monsters is positief geïdentifiseer deur middel van die Mgc2-
PKR terwyl die meeste geïdentifiseer was met die 16S rRNA-PKR.  Hierdie is ŉ 
mootlike aanduiding dat ŉ verskillende M. gallisepticum isolaat geïdentifiseer is 
op die vlak van die 16S rRNA maar nie op die vlak van die Mgc2 geen nie. Die 
moontlikheid bestaan egter wel dat hierdie isolaat wel M. imitans kan wees.  In ŉ 
studie van Woese en medewerkers (1985) was die Mgc2 geen uitgewys as een 
van die vinnigste muterende gene as gevolg van aanpassing en mag dalk nog ŉ 
rede wees waarom identifikasie deur gebruik te maak van die Mgc2  geen 
onsuksesvol was.  
 
Homologie van die basisopeenvolgings van die 16S rRNA PKR produkte was die 
hoogste tussen M. gallisepticum en M. imitans.  Daar is egter slegs twee 
volledige basisopeenvolgings van die 16S rRNA geen beskikbaar op die 
Genbank databasis wat behoort aan twee stamme van M. gallisepticum  wat 
inligting oor die isolate beperk.  Restriksie Fragment Lengte Polimorfisme (RFLP) 
analises is uitgevoer en gestandaardiseer. Die verwagte profiel is verkry met Ts-
11 maar die ander monsters wat getoets is kon in geen verwysings groep 
geplaas word nie. Resultate het egter gewys dat een van die PKR produkte ŉ 
RFLP profiel gehad het soortgelyk aan die van die 6/85 entstof, verdere analise 
het hierdie resultaat bevestig.  Die basispaaropeenvolging van twee van die PKR 
produkte is bepaal en verder geanaliseer.   
 
Filogenetiese analise het gewys dat een van die PKR produkte groepeer weg 
vanaf die ander Mycoplasma isolate alhoewel die basispaaropeenvolging aandui 
dat dit wel M. gallisepticum of M. imitans is.  In ŉ ander filogenetiese boom toon 
een van die PKR produkte homologie teenoor die patogeniese stamme terwyl die 
ander homologie tot die entstof stam 6/85 toon.  
  91DGJE analise het aangetoon dat die PKR produkte uit ŉ gemengde populasie 
bestaan het en dit kan die mootlike rede wees waarom die basisopeenvolging 
van hierdie monsters nie  bepaal kon word nie. Dit kan dalk ook beteken dat daar 
ŉ gemengde infeksie was in die voëls.  Dit was egter verwag dat 16S rRNS 
resultate hierop moes gewys het.  Volgens DGJE analise is die entstof stam Ts-
11 gebruik om sommige van die voëls in te ent terwyl ander met die wilde tipe 
Mycoplasma geïnfekteer was.  Die resultate dui ook tot die moontlike 
teenwoordigheid van twee kopieë van die geamplifiseerde deel van die 16S 
rRNA geen in die entstof stam.  
 
Hierdie studie het die teenwoordigheid van M. gallisepticum en die moontlike 
teenwoordigheid van M. imitans bevestig. Verskillende, maar naby verwante 
Mycoplasma  isolate, is ook teenwoordig in Suid-Afrika. Hierdie kan unieke 
stamme of spesies verteenwoordig en regverdig verdere ondersoek om dit te 
bevestig.  
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